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Objective: Patients with dysphagia, who are unable to meet their daily hydration and 
nutritional needs orally, may require enteral nutrition, either via a nasogastric tube (NGT) as 
a short term provision, or via a gastrostomy tube for longer term provision. The presence of 
dysphagia, specific medical conditions and the presence of comorbidities place patients, who 
require enteral nutrition, at risk for mortality. High rates of mortality are reported in 
international literature, in patients following the placement of long term enteral nutrition via 
percutaneous endoscopic gastrostomy (PEG). High mortality rates following the placement of 
enteral nutrition in patients treated by Speech Language Therapists (SLTs) at Chris Hani 
Baragwanath Academic Hospital (CHBAH) were noted anecdotally. No study has previously 
been done to analyse the outcomes and risks of the placement of enteral nutrition in the adult 
population with dysphagia in the South African context. This study aimed to compare 
survival times in patients with dysphagia, who had a single morbidity and multiple 
morbidities, who were recommended for enteral nutrition to those who were recommended 
for oral palliative nutrition, and the risks associated with a higher risk of mortality post 
placement of enteral nutrition. Design: The study employed an observational cohort design, 
using both retrospective and prospective methods. Three cohorts were included in the study. 
1) Participants with multiple morbidities who were recommended for enteral nutrition 
(n=212), 2) Participants with a single morbidity who were recommended for enteral nutrition 
(n=35) and, 3) Participants who were placed on oral palliative nutrition (n=10). Results: A 
high rate or mortality was noted in all participants who were placed on enteral nutrition 
(regardless of it being NGT or PEG). Survival time was longer in participants with a single 
morbidity (54 days) compared to those with multiple morbidities (24 days) who received a 
PEG. Survival of participants with multiple morbidities who were on oral palliative nutrition, 
was only five days less (19 days) than participants with multiple morbidities who had a PEG 
placed. Mortality rates were high following the placement of enteral nutrition which could be 
attributed to the participants underlying medical condition and level of morbidities present. 
Conclusion: Findings of this study highlight the need for greater consideration of the risk 
factors that may place a patient at risk of mortality following the placement of enteral 
nutrition. It brings into question the futility of some PEG procedures in a cohort of 
participants that show such poor survival, and encourages clinicians to explore the option of 
oral palliative nutrition as a recommendation for patients who are expected to have a high 
risk of mortality if recommended for and placed with enteral nutrition.   
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Comorbidity: A comorbidity refers to the presence of one or more disorders or diseases that 
co-occur with the primary medical diagnosis. In this research study an adjusted version of 
The Charlson Comorbidity Index was used to rate the level of comorbidity present within 
participants (Charlson, Pompei, Ales & MacKenzie, 1987).  
Enteral nutrition: Throughout the document the term ‘enteral nutrition’ will refer to enteral 
tube feeding. The term ‘enteral nutrition’ is defined as “…the provision of nutrition into the 
stomach or small intestine and including both oral nutritional supplements and tube feeding” 
(Lochs et al., 2006), but it is acknowledged that in many research studies (Lochs et al., 2006) 
it refers to “tube feeding”. 
Long term enteral nutrition: The provision of feeds via a tube placed in the stomach using 
the method of percutaneous endoscopic gastrostomy (PEG), which is the preferred method 
used at Chris Hani Baragwanath Academic Hospital (CHBAH). The method of long term 
tube placement via open gastrostomy was not used in this study population.  
Multiple morbidities: A participant with multiple morbidities had a primary medical 
diagnosis along with two or more comorbidities, such as hypertension, diabetes, respiratory 
disease, renal disease, liver disease, paralysis or cardiac conditions. These participants had a 
high comorbidity score (>4) when calculated using The Charlson Comorbidity Index. The 
level was set at >4 (and not >5, which is noted as “high” in the Index) in accordance to a 
study that used the same method to assess morbidity in participants following PEG placement 
(Kobayashi, Cooper, Chak, Sivak & Wong, 2002). 
Oral palliative nutrition: This refers to the approach that was used if a participant was noted 
to have a large number of risk factors that would place them at risk for mortality following 
the placement of enteral nutrition. Instead of being recommended for enteral nutrition, these 
participants were counselled about maintenance of hydration and nutrition in the safest way 
and were left on oral intake as a form of palliation.   
Short term enteral nutrition: The provision of feeds via a nasogastric tube (NGT). 
Single morbidity: A participant with a single morbidity had a single medical condition with 
no co-occurring morbidities. Examples of a single morbidity within the study population 





were: 1) head and neck cancer, 2) a traumatic brain injury, and 3) a hypoxic injury as a result 





















   





Introduction and Rationale 
Whilst working in the adult wards at Chris Hani Baragwanath Academic Hospital (CHBAH) 
for two years, a high mortality rate was noted by a Speech Language Therapist (SLT) in the 
patient population receiving long term enteral nutrition. These patients had various medical 
conditions and had been assessed by an SLT and were diagnosed with dysphagia which 
prevented them from being able to take nutrition or hydration orally. The SLT began a search 
of current literature to determine if high mortality in populations fitted with long term enteral 
nutrition was specific to the population at CHBAH, or if it was a global trend.  A large 
amount of literature documenting high mortality rates in patients fitted with long term enteral 
nutrition, and the risk factors associated with mortality, was found from a number of studies 
across the world (Abuksis, Mor, Plaut, Fraser & Niv, 2004; Blomberg, Lagergren, Martin, 
Mattsson & Lagergren, 2011; Gumaste, Bhamidimarri, Bansal, Sidhu, Baum & Walfish, 
2014; Gundogan, et al ,2014; Grant, Rudberg & Brody, 1998; Ha & Hauge, 2003; Johnston, 
Tham & Mason, 2008; Kobayashi et al.,  2002; Kurien, McAlindon, Westaby & Sanders, 
2010;  Laskaratos et al.,  2013; Lee et al.,  2013; Malmgren, Hede, Karlstrom, Cederholm, 
Lundquist, Wiren & Faxen-Irving, 2011; Nair, Hertan & Pitchumoni, 2000; Poulose, Kaiser, 
Beck, Jackson, Nealon, Sharp & Holzman, 2013; Prosser-Loose & Paterson, 2006; Richards, 
Tanikella, Arora, Guha & Dekovich, 2013; Richter-Schrag, Richter, Ruthmann, Olchewski, 
Hopt & Fischer, 2011; Smith, Perring, Engoren & Sferra, 2008; Smoliner, Volkert, Wittrich, 
Sieber & Wirth, 2012; Zopf, Maiss, Konturek, Rabe, Hahn & Schwab, 2011). The risk factors 
included the presence of certain medical conditions, a high rate of comorbidities, age over 60 
years, a blood albumin level of lower than or equal to 35 g/L and a body mass index (BMI) of 
lower than or equal to 18.5 kg/m² (Abuksis et al., 2004; Grant et al., 1998; Ha & Hauge, 
2003; Johnston et al., 2008; Kirchgatterer et al., 2007; Malmgren et al., 2011; Poulsen, 2009; 
Richter-Schrag et al., 2011; Smith et al., 2008; Smoliner et al., 2012; Zopf et al., 2011). 
Late in 2012 the Speech Therapy team working with the adult population at CHBAH, 
reviewed and modified the SLT criteria for the recommendation of long term enteral nutrition 
based on current literature. The reviewed criteria was implemented in January 2013. 
 
 





Criteria for recommendation of PEG before research into risk factors for mortality post 
placement (pre 2013) 
Any patient with dysphagia who was assessed by an SLT and was found to be unable to take 
nutrition and hydration orally were recommended for enteral nutrition. In some cases long 
term enteral nutrition, via percutaneous endoscopic gastrostomy (PEG), was recommended 
after the first assessment. The indications for the recommendation of enteral nutrition 
included patients who had dysphagia affecting ability of oral intake, patients who were 
unresponsive on assessment, due to decreased levels of arousal, and patients who refused oral 
intake, often due to the presence of dementia or reduced cognitive ability.  
The decision to recommend either short or long term enteral nutrition was made by the SLT 
who assessed the patient. Short term enteral nutrition was recommended if a patient had 
recently been admitted to hospital, was in the acute stages of illness and the SLT determined 
that the patient would benefit from therapy to remediate the dysphagia, and would not require 
tube feeds for a long period. Long term enteral nutrition was recommended if a patient had 
already been on short term enteral nutrition for a period longer than 4 weeks at the time of 
assessment by an SLT, if a patient had decreased arousal for several days or weeks, making 
an assessment by an SLT impossible or if a patient had shown limited or no progress in 
therapy that aimed to remediate dysphagia.  
When referring patients for long term enteral nutrition, an SLT considered only the patients 
inability to take nutrition and hydration orally for an extended period. Aspects like patient 
age, current nutritional status, medical condition and prognosis, and how these may affect 
patient survival after the placement of long term enteral nutrition, were not considered in the 
decision making process. 
Criteria for the recommendation of PEG when risk factors leading to mortality post 
placement were considered before a recommendation was made (2013- present)  
In line with current literature (Abuksis et al., 2004; Blomberg, Lagergren, Martin, Mattsson, 
& Lagergren, 2012; Ha & Hauge, 2003;  Johnston et al., 2008; Kobayashi et al., 2002; 
Malmgren et al., 2011; Nair et al.,  2000; Prosser-Loose & Paterson, 2006; Richards et al., 
2013; Richter-Schrag et al., 2011; Smith et al., 2008; Smoliner et al., 2012; Zopf et al., 2011) 
the decision to refer a patient for the placement of long term enteral nutrition changed to take 
into consideration many aspects that were not previously considered. A patient would only be 
Risks and outcomes for enteral nutrition among adults with dysphagia at a tertiary level hospital in 
South Africa 
14 
considered and recommended for PEG placement if they were expected to have a good 
prognosis for survival post placement (Abuksis et al., 2004). Risk factors that may increase 
the chance of mortality post placement of PEG were considered and if a patient fell into a 
high risk category then they were not referred for the procedure (Johnston et al., 2008; Zopf 
et al., 2011). Risk factors included an age over 60 years, a BMI lower than 18.5 kg/m², 
decreased nutritional intake during the period of hospitalisation, medical diagnosis and the 
presence of comorbidities, such as diabetes, cardiovascular disease and respiratory 
difficulties.  
Patients who were considered high risk and therefore not appropriate candidates for long term 
enteral nutrition were counselled by an SLT, with their family members, on the option of oral 
nutrition, with the possible risk of aspiration and/or inadequate intake, as an alternative to 
PEG placement which carried significant risk of mortality post placement due to the patients 
existing risk factors. These patients were discharged from the hospital or from Speech 
Therapy services on what was termed “oral palliative nutrition”. This term refers to the intake 
of patients who had oral pharyngeal phase dysphagia and/or inadequate intake on oral feeds 
but who had a poor prognosis and for whom PEG would have been a futile procedure. Instead 
of aggressive intervention with the placement of a long term feeding tube, these patients were 
recommended for a palliative approach to feeding intervention, with supported education on 
maintenance of hydration and nutrition and safety via oral intake.  
The aim of this research was to compare two different approaches, used by SLTs working at 
a tertiary level hospital in South Africa, around the recommendation of method of intake in 
patients with dysphagia who had multiple morbidities. Survival times were analysed to 
determine which approach yielded the best result for the patient, so that an SLT could be 
better informed of aspects to consider when recommending a method of intake within this 
population, to ensure highest survival time. It was an intention of the researcher, that the 
results of this study be considered in the creation of a protocol that can be used by SLTs, in a 
hospital setting, when recommending enteral nutrition for patients with oral pharyngeal 
dysphagia, to ensure best outcomes for patients.  
An SLT is not the only professional who can recommend enteral nutrition for a patient with 
dysphagia. In many cases a medical Doctor will do this, without referral to an SLT for 
assessment and management. This study included a group of patients with a single morbidity, 
with dysphagia, who were referred for enteral nutrition by a medical Doctor, but were never 
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assessed or managed by an SLT. The reason for the inclusion of this group of patients was to 
compare the survival times of patients with dysphagia, with a single morbidity versus 
multiple morbidities, who were recommended for different types of intake (NGT, PEG and 
oral palliative intake), in order to inform decisions for the recommendation of method of 
intake for patients with dysphagia. 
Research Context 
In order for the reader to understand the context of the study it is necessary for the researcher 
to provide information about the setting in which the study was conducted as well as the 
processes within the hospital with regards to referral criteria and treatment methods for 
patients with dysphagia. 
CHBAH is a tertiary level hospital situated in Soweto in the Province of Gauteng and is 
financed by the Gauteng Provincial Government. It is the largest hospital in Africa with 2800 
beds and over 4690 staff members. A tertiary level hospital by nature is expected to receive 
referrals from provincial hospitals and provide services based on speciality and not 
geographical location (Mohapi & Basu, 2012). CHBAH serves the population of Soweto but 
also offers services to patients from many different districts and provinces, due to its 
availability of specialised services.   
South Africa is unique to other countries in that it has a quadruple burden of disease with its 
death and disability attributable to four areas; 1) Communicable/maternal/perinatal/ 
nutritional diseases, 2) Non-communicable diseases, 3) Injuries and 4) Human 
Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) (Bradshaw 
et al., 2002). Communicable, nutritional diseases, non-communicable, injuries and 
HIV/AIDS all play a large role in the presentation of adult patients with dysphagia who are 
admitted to tertiary level hospitals in South Africa and require assessment and treatment by 
an SLT.  
A SLT working within the South African context will play a role in the rehabilitation of 
people who fall into the various categories of burden of disease. Dysphagia can result from 
many different disease categories and is commonly assessed and managed by the SLT, with 
recommendation for enteral nutrition commonly made. 






A patient who is suspected of having dysphagia will be referred to an SLT by another health 
care provider, for example, the medical doctor, nurse, or a member of the allied medical 
team. The SLT will assess and manage the patient and recommend either oral or non-oral 
intake. If a patient requires short term enteral nutrition then the SLT will discuss the option 
with the patient and note it in the. A medical doctor or a nurse is responsible for placement of 
a nasogastric tube (NGT). A referral will then be made to a dietician for further enteral 
nutrition follow up. 
 
A recommendation of an NGT or a PEG did not necessarily result in the placement of one. 
Reasons for non-placement are discussed as part of the study results. The primary method of 
enteral nutrition which is being recommended is documented in the hospital file by the 
professional who makes the recommendation. A patient who is referred for PEG will have an 
NGT placed as an interim measure to provide hydration and nutrition whilst awaiting PEG 
placement. Such a patient could then be noted as having been recommended for both NGT 
and PEG.  
If long term enteral nutrition is recommended by the SLT, it will be documented in the 
hospital file and discussed with the patient and medical doctor. If the patient consents to the 
placement of long term enteral nutrition, the medical doctor will organise with the 
gastroenterologist for the patient to be booked onto the procedure list. The most common 
method of placement of long term enteral nutrition at CHBAH is via a PEG. If a patient has 
anatomical abnormalities that make a PEG impossible then there is referral for a gastrostomy.  
Patients who were assessed and managed by Speech Therapy at CHBAH had multiple 
morbidities, which refers to the co-occurrence of two of more medical conditions (Whitson & 
Boyd, 2014). These can include hypertension (HPT) and diabetes, cardiovascular disease, 
respiratory disease, malnutrition, hemiplegia, HIV/AIDS, tumours, lymphoma, liver disease, 
renal failure and psychiatric disorders (Quan et al., 2005).  
The Charlson Comorbidity Index (Appendix A) is a measure of comorbidity and the effects 
thereof on a patient’s survival rate after a medical procedure. It is used in many institutions as 
a method to determine if a particular form of aggressive intervention, such as a surgery, is 
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indicated and justified in a patient according to their comorbidities. Patient comorbidity is 
scored according to the effect the comorbidity will have on survival. The cumulative score is 
classified into mild, moderate or high risk with a score of equal to or over five being 
considered high risk (Charlson et al., 1987). The age adjusted Charlson comorbidity scale 
takes a patients age into consideration when it calculates a risk score, as age is noted to have 
a direct effect on survival.  Kobayashi et al. (2002) used an adapted Charlson comorbidity 
scale to determine the appropriateness of referral for PEG placement and set their level of 
high risk to a score equal to or above four. Patients with a score equal to or higher than four 
had an increased risk of mortality post-surgical procedure. The scale is not used at CHBAH 
as a standard measure when assessing the appropriateness of a recommendation for a PEG, 
but it was used as a tool within this study as it was noted to be valuable in categorising high 
risk patients in the study by Kobayashi et al. (2002).    
Important to note are the different applications of The Charlson Comorbidiy Index that this 
study used. In this study the primary medical diagnosis of the participant was not included in 
the scoring of morbidity on the Charlson Comorbidity Index. Only concomitant disorders 
were noted as comorbidities. For example: on the index, a score of “6” is given to a patient 
with a cancer, but in this study a participant who had head and neck cancer and no other 
comorbidities was not given a score of “6” but was rather classified as having a single 
morbidity. Another point to note is the inclusion of HIV/AIDS as a morbidity on the index. 
The original Charlson Comorbidity Index which was developed in the 1980s and attributed a 
high score to persons with HIV/AIDS. The reason for the high score was due to the high rate 
of mortality in persons with HIV/AIDS at that time. There has been a greater survival rate in 
this population due to the introduction of antiretroviral medications, so it is argued that the 
scoring on the Charlson Comorbidity Index, for these patients, should be adjusted as they 
now have an improved prognosis (Zavascki & Fuchs, 2006). The researcher agrees with this 
suggestion, but as it is not suggested what score should now be attributed to patients with 
HIV/AIDS, the researcher decided to omit the inclusion of HIV/AIDS as a comorbidity in 
this study.  
The change in criteria for which patients were referred for long term enteral nutrition, made 
by the Speech Therapy Department at CHBAH and implemented in January 2013, introduced 
the option of “oral palliative nutrition”. A patient with dysphagia who was considered to have 
a poor chance of survival post PEG insertion, because of the presence of risk factors which 





increased their chance of mortality, could now be offered an option other than enteral 
nutrition as a method of intake. Literature refers to patients who deferred PEG placement 
until they were well enough to undergo the procedure when a positive outcome was expected 
(Abuksis et al., 2004). Under the revised criteria that was implemented by the Speech 
Therapy Department at CHBAH, a patient did not defer PEG placement, as they never came 
back in the future for placement, but rather were recommended for “oral palliative nutrition” 
and managed with supportive education on maintaining hydration and nutrition in the safest 
way considering their diagnosis of dysphagia.  
Patients who were referred for enteral nutrition by a medical Doctor typically had a single 
morbidity. The main medical diagnosis in this cohort was head and neck cancer, with the 
remaining conditions including trauma as a result of traumatic brain injury (TBI), a single 
case of a degenerative neurological disorder and three cases where patients had a hypoxic 
episode in theatre as a result of cardiac arrest and were unconscious for a period afterwards 
and were subsequently recommended for and received a PEG. None of these patients had co-
occurring medical conditions and were hence classified as having a single morbidity.  
 
Literature Review 
Enteral feeding is defined as the provision of nutrition into the stomach or small intestine and 
includes both oral nutritional supplements and tube feeding (Lochs et al., 2006). It is 
acknowledged that many research studies refer to enteral nutrition only as tube feeding 
(Lochs et al., 2006), which is the definition that will be used in this study. Provision of 
enteral nutrition can be is indicated for a number of reasons. Patients who need optimal 
hydration and nutrition in order to meet daily nutritional requirements, but are unable to gain 
this orally due to the presence of oral or pharyngeal phase dysphagia as a result of their 
medical condition, will require enteral nutrition (Bankhead et al., 2009; Blomberg et al., 
2012; DiBaise & Scolapio, 2007; Erdil, Saka & Ates, 2005; Gundogan et al., 2014; Holmes, 
2011; Sharp & Shega, 2009; Vivanti, Campbell, Suter, Hannan-Jones & Hulcombe, 2009). 
This would include patients who are unable to swallow due to neurological damage or 
degeneration (DiBaise & Scolapio, 2007; Kobayashi et al., 2002; Nicholson, Korman, & 
Richardson, 2000; Paramsothy, Papadopoulos, Mollison & Leong, 2009; Prosser-Loose & 
Paterson, 2006; Rio et al., 2010; Stroud, Duncan & Nightingale, 2003), or those who have 
structural abnormalities that make oral nutrition impossible, as in the case of patients with 





advanced stage head and neck cancer or oesophageal cancer (Baldwin et al., 2011; Nguyen et 
al., 2006; Wermker, Jung, Huppmeier & Kleinheinz, 2012). Patients with head and neck 
cancer may also be at risk for developing dysphagia after treatment as a result of tissue 
damage to the swallow mechanisms from radiation (Wermker et al., 2012) and may be 
recommended for prophylactic PEG placement (Ngugen et al., 2006). Patients with head and 
neck cancer may be able to receive oral nutrition, but may also require enteral nutrition as a 
supplement to oral intake to ensure sufficient intake of daily nutritional requirements when 
receiving radiotherapy (Wermker et al., 2012). In the cases of trauma to the body, or after 
surgery, enteral nutrition is also recommended to aid with sufficient caloric intake to 
minimise loss of body fat and aid recovery (de Aguilar-Nascimento, Bicudo-Salomao, & 
Portari-Filho, 2012; Darbar, 2001; Hartl, Gerber, Quanhong & Ghajar, 2008; Stroud et al., 
2003; Vassilyadi, Panteliadou, & Panteliadis, 2013; Vizzini & Aranda-Michel, 2011). 
Patients with certain medical conditions are more likely to require enteral nutrition because of 
concomitant dysphagia or increased nutritional needs. The most common indicator for long 
term enteral nutrition is cerebral vascular accident (CVA), as noted in many studies with 
sample sizes varying between 42 and 1041 (Blomberg et al., 2012; Erdil et al., 2005; Janes, 
Price & Khan, 2005; Kirchgatterer et al., 2007; Kobayashi et al., 2002; Lee et al., 2013; 
Malmgren et al., 2011; Nicholson et al., 2000;  Paramsothy et al., 2009; Richter-Schrag et al., 
2011; Smith et al., 2008; Smoliner et al., 2012; Thomson, Carver, & Sloan, 2002). Dysphagia 
with resulting malnutrition and/or dehydration is common in patients who have had a CVA, 
explaining the high need for enteral nutrition within this population (Crary Humphrey, 
Carnaby-Mann, Sambandam, Miller & Silliman, 2012; Kobayashi et al., 2002; Prosser-Loose 
& Paterson, 2006; Sura, Madhavan, Carnaby & Crary, 2012). Patients with other neurological 
deficits, such as those with traumatic head injury or neuro-degenerative diseases, may also 
require short or long term enteral nutrition as a safe method to gain hydration and nutrition 
(Darbar, 2001; Denes, 2004; Hartl et al., 2008; Holmes, 2011; Vizzini & Aranda-Michel, 
2011; Zhang, Sanders & Fraser, 2012).  
There are different methods of enteral nutrition, each with specific indicators, benefits and 
challenges. The route of enteral nutrition chosen is determined according to the length of time 
for which enteral support is required and the type of enteral support needed for a specific 
patient. The different types of enteral nutrition available are nasogastric tubes (NGTs), 
nasojejenal tubes (NJTs), gastrostomy tubes (GTs) and jejenostomy tubes (JTs), percutaneous 
endoscopic gastrostomy (PEG) or percutaneous endoscopic jejenostomy (PEJ).  





Before the development of percutaneous endoscopic placement of feeding tubes by Gauderer 
& Ponsky in the early 1980s, the procedure to place a tube had to be done under general 
anaesthetic. PEG has now become the most popular form of placement of tubes for the 
provision of long term enteral nutrition because of the ease of insertion which is minimally 
invasive and does not require general anaesthetic (Laskaratos et al., 2013; Swaminath, 
Longstreth, Runnman & Yang, 2010; Wilhelm, Ortega & Stellato, 2010). A surgical 
gastrostomy may still be performed in cases where PEG is not possible due to obstruction 
which makes the passing of the scope down the gastrointestinal tract impossible (McClave & 
Chang, 2003). Higher complication rates after the placement of a feeding tube via open 
gastrostomy were noted (Dwyer, Watts, Thurber, Benoit & Fakhry, 2002; Moller, Lindberg 
& Zilling, 1999) when compared to the complications post placement of a PEG. These 
complications included, internal leakage, peritonitis, fistula, dislodgement, external leakage 
and skin infection. Higher mortality rates were noted in patients who had a surgical 
gastrostomy performed (29%, n=35) versus those who had a PEG (17%, n=12), although 
differences in mortality between the groups were not significant (Moller et al., 1999).   
The provision of nutrition into the stomach via NGT or gastrostomy/PEG is common (Erdil et 
al., 2005; Lee et al., 2013), but gastrointestinal intolerance of tube feedings, which are 
identified by the presence of large gastric residual volumes, nausea and vomiting, ileus, 
abdominal distension, and diarrhoea (MacDougall, 2010) is a major factor limiting adequate 
enteral intake in patients. In cases such as these the stomach may be bypassed and nutrition 
delivered to a lower part of the gastro intestinal tract (Codner, 2012; DiBaise & Scolapio, 
2007; McClave & Chang, 2003). Benefits of NJT/PEJ feeding include an improvement in 
energy intake due to improved absorption in the small bowel and a decreased risk of reflux 
related aspiration due to feeds being delivered into an area further away from the pharynx 
(Hsu et al., 2009). This benefit however is not noted in all literature with no difference in 
energy intake and risk of aspiration between NGT and NJT fed patients noted by Davies et al. 
(2012).  
The benefits within various groups of patients of early enteral nutritional have been 
documented (Davies et al., 2012; Doig, Heighes, Simpson & Sweetman, 2011; Lu, Huang, 
Yu, Zhu, Cai, Gu & Su, 2011; Silva et al., 2013). It is recommended that for the delivery of 
early enteral nutrition, the placement of NGTs be utilised in the acute stages of disease 
(Bankhead et al., 2009; Dziewas et al., 2002; Kobayashi et al., 2002; Maitines, Ugenti, 
Memeo, Clemente & Lambrenghi, 2009; Prosser-Loose & Paterson, 2006). NGTs are 





indicated for short term use only and should not be in situ for a period of longer than 4 - 6 
weeks (Bankhead et al., 2009; Stroud et al., 2003), as they can cause serious complications 
including nasal ulceration, chronic sinusitis and increased risk of aspiration pneumonia 
(Azzopardi & Ellul, 2013; McClave & Chang, 2003; Stroud, et al.,  2003).  
NGTs have benefits in that they are easy to insert and require no surgical procedure or 
administration of anaesthetics for placement (Gomes, Lustosa, Matos, Andriolo & Waisberg 
& Waisberg, 2012; Kobayashi et al., 2002; Rio et al., 2010) however they have many known 
associated risks. They are poorly tolerated by patients and are often pulled out after insertion, 
which reduces the nutritional advantage which was the aim of placement (Beavan et al., 
2010; Kim, Stotts, Froelicher, Engler, Porter & Kwak 2012; Roy, Person, Souday, Kerkeni, 
Dib & Asfar, 2005). NGTs are often placed incorrectly by the professional inserting them, 
with incidence reported to be 0.3-27%, as cited in Hegde & Rao (2010). A misplaced NGT 
can result in aspiration pneumonia which can be fatal (Hegde & Rao, 2010). Patient 
positioning during NGT feeding can also result in aspiration pneumonia with most 
hospitalized patients being in a sedated state or lying flat when feeds are given via the NGT 
(Dziewas et al., 2004; Mizock, 2007). An increase in reflux with NGT placement is noted 
(Gomes et al., 2012; McClave & Chang, 2003) particularly if patients had pre-existing gastro-
oesophageal reflux (GOR) (Jung et al., 2011). Similar negative effects are noted with the use 
of PEGs with no difference in complications from NGT versus PEG (Gomes et al., 2012).  
If a patient requires enteral nutrition for a period longer than 4-6 weeks, and their prognosis 
justifies the intervention, placement of a long term tube for the provision of enteral nutrition 
should be recommended (Abuksis et al., 2004 Janes et al., 2005; Johnston et al., 2008; Rio et 
al., 2010) in the form of a gastrostomy or PEG tube. There are some contrasting views, 
however, with one study suggesting waiting for a period of at least 6-8 weeks with an NGT in 
situ, before considering insertion of a PEG to ensure a better prognostic outcome (Maitines et 
al., 2009). Others do not consider time as a factor, in the decision to recommend long term 
enteral nutrition, but rather the prognosis of the patient and argue that a patient in the end 
stages of disease should not be considered for PEG but should rather receive nutrition via 
NGT (Rio et al., 2010).  
The placement of a PEG for the provision of enteral nutrition is considered a life-saving 
procedure in some cases (Anis et al., 2006; Jordan, Philpin, Warring, Cheung & Williams, 
2006) and many patients who have a PEG attest to this fact and the benefit that PEG feeding 





provides them (Anis et al., 2006; Osborne, Collin, Posluns, Stokes & Vandenbussche, 2012). 
One study noted particularly positive patient reports on their experiences living with a PEG 
tube, with 84% (N=51) noting a positive or neutral effect of the tube on their lives, 90% 
(N=51) expressing a view that the tube was worthwhile and 96% (N=51) noting that they 
would recommend it to another patient (Osborne et al., 2012).  
Negative experiences of patients who have a PEG tube and the negative impact that a PEG 
has on a patients quality of life, are extensively reported on in the literature. Common 
difficulties associated with having a PEG tube, which affect quality of life, include a high 
level of complication, like tube blockage, leakage and discomfort (Rogers, Thomson, 
O’Toole & Lowe, 2007), interference with family life, social activities and hobbies 
(Brotherton, Abbott & Aggett, 2006; Jordan et al., 2006; Martin, Blomberg  & Lagergren, 
2012; Rogers et al., 2007), interference with intimacy (Rogers et al., 2007), negative 
reactions from others (Brotherton et al., 2006), a burden placed on family or caregivers 
(Brotherton et al., 2006) and a feeling of missing out on meal times and food (Brotherton et 
al., 2006). Similar negative effects on quality of life are reported in patients who receive NGT 
feeds (Brotherton & Judd, 2007), but the majority of literature focusses on assessment of the 
quality of life of patients who receive enteral nutrition via a PEG because PEG is used for 
long term delivery of enteral nutrition. A study in Taiwan noted that the majority of patients 
in Taiwan are discharged home on NGT feeds because of a refusal to have a PEG placed 
(Lin, Li & Watson, 2011). The reasons given for a refusal of PEG by the patient or their 
caregivers are concern over leakage and infection following a PEG, a worry that the patient is 
too old and frail to undergo an operation and a cultural belief that the patient will not die 
“whole” if they have a PEG in situ (Lin et al., 2011).  
Despite the benefits that a PEG tube can provide a patient, such as improved nutrition and a 
longer survival time, quality of life is affected (Jordan et al., 2006). There is a need for health 
care professionals to counsel patients on the effects that a PEG tube will have on their quality 
of life (Rogers et al., 2007), by shifting the focus of management post PEG insertion to 
include social aspects and not only clinical needs (Brotherton et al., 2006).  
PEGs, GTs and NGTs all have advantages and possible complications. The outcomes 
discussed in literature relate to mortality and improved nutrition. Adequate nutrition is 
closely linked to better results in medical outcomes and survival (Codner, 2012; Vassilyadi et 
al., 2013). PEG is noted to be superior to NGT with regard to improvement in general 
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medical outcomes (Gomes et al., 2012) with NGT candidates being statistically more prone 
to intervention failure, such as tube blockage or leakage, feed interruption and recurrent 
displacement, than patients who were fitted with PEG, regardless of the patient’s underlying 
medical condition (Gomes et al., 2012). With better provision of feeds when a PEG is used, 
better medical outcomes can be expected as a patient is more likely to receive adequate 
hydration and nutrition.  
No difference was found in the rate of complications between NGT and PEG cohorts, with 
42% (n=105) of patients with PEG and 42.68% (n=108) of patients with NGT experiencing 
complications post placement (Gomes et al., 2012). The rate of mortality that each group of 
patients faced post placement was not significantly different, with rates of 37.24% (n=105) 
and 35.71% (n=105) respectively in patients with PEG and NGT (Gomes et al., 2012). There 
was no difference in mortality rate (Azzopardi & Ellul, 2013; Gomes et al., 2012) or the 
occurrence of pneumonia post placement (Gomes et al., 2012). When patients who had a 
CVA were considered as a separate group from other medical conditions, neither NGT nor 
PEG were superior in the delivery of nutrition. The presence of dysphagia was the key 
indicator for mortality rather than the type of enteral nutrition used (Laskaratos et al., 2013).  
There exists debate around which method of enteral intake is best suited for patients with 
head and neck cancer specifically. A large majority of patients with cancer are malnourished 
throughout the disease process and will require enteral nutrition (Sobani, Ghaffar & Ahmed, 
2011). When considering which method of enteral nutrition to recommend in this patient 
population one needs to consider the benefits and drawbacks of both methods. In one study, 
PEG is noted to be superior to NGT as it resulted in greater weight gain and lower mortality 
(Sobani et al. 2011) but others note a lower clinical risk of complications, and a greater 
chance of returning to full oral feeds after a six month period, with patients left on NGT feeds 
rather than fitted with PEG (Sheth, Sharp & Walters, 2013).  It is argued that a patient with 
an NGT will be more eager to feed orally in order to progress towards removal of the tube 
because of the visibility of an NGT, which can be unsightly to some. Beginning partial oral 
intake makes muscle atrophy less likely and speeds up the return to full oral intake, compared 
to those receiving nutrition exclusively via a PEG (Sheth et al., 2013).  
Poor nutrition is linked directly to poor outcomes, specifically an increased rate of morbidity 
and mortality (Codner, 2012; Vassilyadi et al., 2013). It has been established through a 
review of various studies that a patient who is fed via a PEG has a lower chance of 





intervention failure (Gomes et al., 2012), which is the failure to start tube feeds after a 
recommendation has been made. Intervention failures include non-adherence to tube usage, 
interrupted feeds, a blocked or leaking tube and misplacement of tubes (Gomes et al., 2012). 
All of these factors are commonly noted with the use of NGT (Kim et al., 2012; MacDougall, 
2010). It then follows that a patient who is fed via a PEG will have less intervention failure, 
which will facilitate improved nutrition, which in turn improves clinical outcomes.  
Factors other than improved nutrition need to be considered when comparing the outcomes 
associated with enteral nutrition via PEG and NGT. Gomes et al. (2012) noted no difference 
in mortality rates post insertion between patients with dysphagia, with varying medical 
conditions including neurological fallout and head and neck cancer, who received enteral 
nutrition via a PEG versus an NGT. When considering mortality as an outcome after PEG 
placement, its rate as a direct result of a PEG procedure is low (Blomberg et al., 2011; 
Nicholson et al., 2000). Mortality rate in the first few weeks post PEG is noted to be ‘high’ 
(Malmgren et al., 2011) with varying reports of percentages ranging between 10% and 36% 
depending on sample size and medical conditions included (Abuksis et al., 2004; Erdil et al., 
2005; Ha et al., 2003; Johnston et al., 2008; Keung, Liu, Nuzhad, Rabinowits & Patel, 2012; 
Malmgren et al., 2011; Sanders, Carter, D’Silva, James, Bolton & Bardhan, 2000). In one 
study, patients with dementia were separated from the other medical conditions, and the 30 
day mortality rate was high at 54% (Sanders et al., 2000). These 30 day mortality figures 
come from both developed and developing countries where a variety of medical conditions 
were included in the sample. When considering the time frames in which patients died post 
PEG placement, the largest majority died within the 30 day period, which is the reason that 




















Medical condition of participants  Country where the study 
was conducted 
Reference  
15.8% 359 Head and neck cancer (n=97) 
CVA (n=73) 
Malignancy (n=61) 
Head injury (n=59) 
Cerebral palsy (n=38)    
Congenital anomaly (n=19) 
Motor neuron disease (n=7) 
Dementia (n=5) 
Bosnia Herzegovina Vanis, Saray, Gornjakovic 
& Mesihovic, 2012 
22% 201 CVA (n=97) 
Malignant oesophageal obstruction (n=33) 
Dementia (n=16) 
Other neurologic disorders (n=13) Parkinsons 
(n=12) 
Other (n=23)  
Other malignancies (n=5)  
Sweden Malmgren et al., 2011 
10% 77 Neurologic disorders (n=71) 
Head and neck cancer (n=6) 
Turkey Ermis et al., 2012 
20% 128 CVA (n=34) 
Non neurologic cerebral hypoxia (n=30) 
Cranial tumour (n=23) 
Head and neck cancer (n=19) 
Motor neuron disease (n=13) 
Other (n=9) 
Turkey  Gundogan et al., 2014 
     
19% 83 CVA (n=83) Norway Ha & Hauge, 2003 
22% 112 CVA (n=33) 
Head and neck cancer (n=27) 
Chronic neurological disorders (n=22) 
Other (n=30)  
Britain  Janes et al., 2005 
18.5% 187 Malignancy (n=187) America Keung et al., 2012 
36% 61  CVA (n=50) 
Dementia (n=21) 
Malignancy (n=9) 
Israel Abuksis et al., 2004 





Head and neck trauma (n=3) 
28% 361 CVA (n=120) 
Dementia (n=103) 
Oropharyngeal malignancy (n=65) 
Other (n=73) 
America Sanders et al., 2000 
 
The reasons for high mortality rates need to be understood so that the rate can be lowered; 
literature notes one of the reasons to be poor patient selection. Patients with risk factors that 
place them at risk of mortality are being recommended for PEG, resulting in poor outcomes 
that are being linked to the PEG procedure, when in fact these patients were at risk of death 
regardless of PEG placement (Kurien et al., 2011; Richards et al., 2013). There is strong 
evidence linking certain underlying medical conditions to higher mortality post insertion 
(Abuskis et al., 2004; Erdil et al., 2005; Grant, Bradley, Pothier, Bailey, Caldera, Baldwin & 
Birchall, 2008; Johnston et al., 2008; Kurien et al., 2011; Laskaratos et al., 2013; Poulose et 
al., 2013; Schettler, Momma, Markowski, Schaper, Klamt, Vaezpour & Schneider, 2013; 
Stroud et al., 2003) with the highest mortality rate being in patients who had CVA and 
malignancies (Malmgren et al., 2011; Poulose et al., 2013).  
The timing of PEG placement (Abuksis et al., 2000; Smith et al., 2008) is noted also to affect 
outcome.  Many authors suggest a delay in the placement of long term enteral nutrition, for 
30 days, to ensure a better chance of survival, leaving patients on short term enteral nutrition 
for a longer period (Abuksis et al., 2000; Smith et al., 2008). Mortality in patients with CVA 
usually occurs in the acute stage when a patient is still in hospital (Cowey, 2012). A patient 
who receives a PEG at this stage is at high risk of dying due to an underlying medical 
condition (Cowey, 2012), and will then reflect high mortality in the statistics of CVA patients 
fitted with PEG. Dysphagia is common with CVA (Cowey, 2012) but many CVA patients 
will regain their ability to swallow within two weeks post infarct (Westaby, Young, O’Toole, 
Smith & Sanders, 2010). The timing for placement of PEG in a patient with CVA is critical, 
and should only be considered if a patient has not regained their ability to swallow within 
four weeks and is no longer in the acute stages post onset (Kumar et al., 2012; Prosser-Loose 
& Paterson, 2006). During the acute stages post CVA, an NGT is recommended for the 
provision of hydration and nutrition (Prosser-Loose & Paterson, 2006).    
Other risk factors that have been found to negatively influence post PEG insertion survival 
rates are noted in the literature, these include increased age, low BMI, low blood albumin 





levels, and a high number of comorbidities. Along with primary medical condition and timing 
of placement, these factors also need to be considered when recommending a patient for the 
procedure to decrease the chance of poor outcomes. One such risk factor is increased age; 
patients over the age of 60 were found, unanimously, to have the highest mortality rate at 30-
days post insertion (Abuksis et al., 2004; Grant et al., 1998; Ha & Hauge, 2003; Johnston et 
al., 2008; Kirchgatterer et al., 2007; Malmgren et al., 2011; Poulsen, 2009; Richter-Schrag et 
al., 2011; Smith et al., 2008; Smoliner et al., 2012; Zopf et al., 2011). Age together with 
diminished mental capacity, as with patients who have dementia, tripled the short term 
mortality post placement (Malmgren et al., 2011), and cautions against PEG placement 
specifically in older patients with dementia.    
Strong evidence links poor nutrition upon hospitalization with poor medical outcomes, such 
as greater incidence of morbidity and mortality (Codner, 2012; Koretz, Avenell, Lipman, 
Braunschweig, & Milne, 2007; Vassilyadi et al., 2013). Malnourishment is measured in the 
literature using the body mass index (BMI), with a BMI of <18.5 indicating malnutrition 
(WHO, 1995). Malnourishment can be as a result of the disease process or due to 
socioeconomic factors (Norman, Pitchard, Lochs & Pirlich, 2008) and can be further 
exacerbated by hospitalization (Codner, 2012; Johnston et al., 2008; Kim et al., 2012; 
Prosser-Loose et al., 2006; Shroud, Duncan, & Nightingale, 2003; Silva et al., 2013; 
Vassilyadi et al., 2013), because of interruptions in the provision of enteral nutrition for 
various reasons, inadequate nutrition prescribed and an inability of a patient, who may be on 
oral intake, to physically eat independently (Norman et al., 2008).  Malnourishment at the 
time of PEG placement was a crucial factor noted to place a patient at risk for mortality 
following the placement of a tube for the provision of long term enteral nutrition (Abuksis et 
al., 2004; Azzopardi & Ellul, 2013; Blomberg et al., 2011; Janes et al., 2005; Johnston et al., 
2008; Zopf et al., 2011).  
Upon admission to hospital an NGT may be placed to improve nutrition before placement of 
a PEG (Blomberg et al., 2011). But NGT feeds can result in minimal improvement in 
nutritional status because of interrupted feeds when a patient goes for a procedure, late 
placement and commencement of feeds or accidental removal of tubes (Beavan et al., 2010; 
Kim et al., 2012; MacDougall, 2010). A nutritionally compromised patient would then 
benefit from placement of a PEG with the aim of improving nutrition, based on evidence that 
PEG placement facilitates better improvement in nutrition (Erdil et al., 2005; Sobani et al., 





2011). PEG placement, however, comes with a high risk of mortality due to the patient’s 
initial poor nutritional status. 
Based on the high mortality rate of malnourished patients, research (Abuksis et al., 2004; 
Azzopardi & Ellul, 2013; Blomberg et al., 2011; Janes et al., 2005; Johnston et al., 2008; 
Zopf et al., 2011) suggests that it is important to consider the nutritional status of individuals 
prior to PEG insertion. A review of the literature on markers of a patient’s nutritional status 
suggests that albumin levels may be used as a marker of malnutrition (Pear, 2007). Albumin 
is a protein made by the liver, and is a measure of protein in the body. Albumin balances the 
amount of blood flowing through the body’s arteries and veins and helps to transport calcium, 
progesterone, bilirubin and medications through the blood. A serum albumin test will 
measure the amount of protein in the blood and can be used as an indicator of the presence of 
liver or kidney disease (Pratt, 2010) which can affect patient survival. Normal levels of 
albumin are considered to be in the range of 3.4-5.4 g/dL or 35-50 g/L, depending on how 
specific laboratories measure it. Literature has noted the link between low albumin levels pre-
insertion of PEG and a high mortality rate post insertion (Blomberg et al., 2011). This link 
confirms that hypo- albuminaemia is a risk factor that should be considered in all patients 
being medically worked up for PEG placement (Azzopardi & Ellul, 2013; Blomberg et al., 
2011; Johnston et al., 2008; Kurien et al., 2011; Nair et al., 2000).  
Various co morbidities like diabetes and cardiac disease were also noted to be significant risk 
factors for high mortality in patients post PEG insertion (Janes et al., 2005; Johnston et al., 
2008; Kurien et al., 2011; Pear, 2007; Zopf et al., 2011).  
Considering the multitude of risk factors that exist for poor outcome post PEG insertion, it 
follows that a patient should be individually assessed for the presence of any risk factors 
before being recommended for the procedure (O’Mahony, 2012; Playford, 2010; Tanswell, 
Barrett, Emm, Lycett, Charles, Evans & Hearing, 2007). A comprehensive assessment 
process by a multi-disciplinary team needs to consider factors such as: 1) the potential 
benefits to the individual should they receive a PEG, 2) biochemical parameters, like blood 
albumin level 3) multiple comorbidities, 4) patient prognosis, 5) and other existing risk 
factors that may place this patient at risk of mortality post procedure, like age over 60 years 
and a low BMI (Azzopardi & Ellul, 2013; Buscaglia, 2006; DeLegge, McClave, Disario & 
Baskin, Brown, Fang & Ginsberg, 2005; Ha & Hauge, 2003;  Janes et al., 2005; Johnston et 
Risks and outcomes for enteral nutrition among adults with dysphagia at a tertiary level hospital in 
South Africa 
29 
al., 2008; Kobayashi et al., 2002;  Longcroft-Wheaton, Marden, Colleypriest, Gavin, Taylor 
& Forrant, 2009; Richter-Schrag et al., 2011; Smoliner et al., 2012; Tanswell et al., 2007).  
If a patient is considered a high risk candidate after the assessment process, then PEG should 
be avoided (Lee et al., 2013). In cases such as these a patient should be counselled 
appropriately on the available options and associated risks of each option of intake, including 
oral, NGT and PEG. A health care professional, either a medical Doctor, an SLT or a 
Dietician, can make a recommendation for enteral nutrition based on their knowledge but a 
cognitively intact patient must make the final decision after being fully informed about the 
benefits and risks involved in all the recommended management plans (DeLegge et al., 
2005).  
There are many ethical considerations that exist around patient care of any kind, like 
autonomy, beneficence, and non-maleficence. It is important to consider these when making 
a recommendation for enteral nutrition. Particularly important, when reflecting on the high 
mortality rate post PEG procedures, is the concept of futility (DeLegge et al., 2005). Futility 
refers to a medical intervention that would have no effect, or if there was an effect, it would 
not be one that the patient benefitted from (DeLegge et al., 2005). Many patients are fitted 
with tubes for the provision of long term enteral nutrition where no effect or benefit is proven 
in terms of nutritional improvement or survival (Johnston et al., 2008).  
This is most particularly noted in the case of patients with advanced dementia being fitted 
with a tube for the provision of long term enteral nutrition (Goldberg & Altman, 2014; 
Sampson, Candy & Janes, 2009). In this population, literature notes that the placement of a 
PEG has no benefit to the patient and can actually lead to decreased survival due to the 
complications, such as aspiration, that result from the placement (DeLegge et al., 2005; 
Sampson et al., 2009). The use of long term enteral nutrition in patients with malignancy, 
with the aim of nutritional gain, needs to be questioned as literature notes no real nutritional 
gain in these patients post placement (Baldwin et al., 2011; Keung et al., 2012; Poulose et al., 
2013).  
Azzopardi & Ellul (2013) raise the point that, in certain patient populations, the insertion of a 
PEG will only prolong a life which is of poor quality and it needs to be determined through 
discussion whether this is ethical. Another consideration in South Africa particularly, is 
whether it is appropriate to perform futile procedures in resource stretched public hospitals 
(Naidoo, 2012). If a PEG is placed in cases where a patient has poor prognosis and is 





considered high risk for mortality post PEG placement, the argument could be made that the 
resources should be spared and be used to provided procedures that will benefit other patients 
who are expected to have a lower mortality rate. 
The use of protocols in patient care ensures that best practice, which is determined from 
literature, is adhered to. They are important documents to which health care professionals 
should refer to guide practice that will result in the provision of the best possible care 
(Heyland, Cahill, Dhaliwal, Sun, Day & McClave, 2010). Protocols for the assessment and 
management of patients with dysphagia who require enteral nutrition do exist (Bankhead et 
al., 2009; Loser et al., 2005; Westaby et al., 2010; Wilhelm et al., 2010) but do not include 
considerations like assessment of risk factors to justify the PEG procedure.  
Although protocols exist (Bankhead et al., 2009; Loser et al., 2005; Westaby et al., 2010; 
Wilhelm et al., 2010), and knowledge around risk factors post PEG are known, adherence to 
protocols cannot be assumed. The presence of risk factors in patients does not always deter a 
health professional in making a recommendation for PEG placement, as is evident in the 
literature, which continues to reveal high mortality rates, despite the knowledge of risk 
factors and their effect on mortality (Johnston et al., 2008).  
The decision to refer a patient for a PEG procedure includes many factors that need to be 
considered together to help clinicians make a recommendation that is in the best interests of 
the patient. The concept of palliative care needs to be introduced as a real alternative for 
patients who are not considered candidates for PEG placement due to the presence of risk 
factors that will put them at high risk for mortality post placement. Palliative care is defined 
as “…an all-encompassing approach to care that begins months or years before death” 
(World Health Organisation 2002). The provision of hydration and nutrition in end of life 
care is an area of debate and can become a highly emotional topic. It is suggested that the 
decision to place a feeding tube revolve around the basic principles of medical ethics 
(Delegge et al., 2005). Informed consent from an adult who is cognitively intact is 
imperative, and the benefits from the placement of enteral nutrition must outweigh the risk of 
the procedure, which should cause the patient no harm (Delegge et al., 2005).    
In the case of many studies cited throughout this literature review, PEG placement does not 
always benefit the patient, and although the actual PEG procedure does not harm the patient, 
the risk of mortality post placement is high, which in turn is harmful to the patient. The 
choice of refusing a PEG and remaining on oral intake as a form of palliative care should be 





made available to all patients and their family members, with provision of education and 
support for the decision they may make. The inclusion of a palliative care option for patients 
who do not wish to have a PEG placed as it would provide them with an alternative option, 
and it would also ensure that futile procedures are avoided which would uphold medical 
ethics.  
Important to note are positive outcomes as a result of long term enteral nutrition, which 
should also guide decisions for recommendation. One such outcome post PEG placement, 
which is discussed in the literature, is the ability to return to oral feeding post placement. 
Return to oral feeding post PEG placement can occur in patient populations with a mixture of 
medical conditions depending on factors such as the presence of dysphagia, age, and the 
underlying medical condition that necessitated PEG placement (Ha & Hauge, 2003; Nguyen 
et al., 2006; Paramsothy et al., 2009). Factors identified in literature that determined a return 
to oral intake, were the ability to take some amount of nutrition orally at 3 and 6 months post 
PEG placement (Paramsothy et al., 2009), regression of the tumour that had originally caused 
dysphagia post chemo/radiotherapy (Nguyen et al. 2006; Paramsothy et al., 2009) and 
regaining of the swallow post CVA (Ha & Hauge, 2003; Paramsothy et al., 2009). In a 
population consisting of 70% (n=302) of patients who had  CVA, Yokohama et al. (2009) 
identify a younger age, the absence of dysphagia and intervention by a speech therapist to 
regain the swallow pre PEG placement, as factors that contribute to a return to oral intake.  
Based on a review of current and available literature, it can be noted that there are various 
risk factors that exist which place patients at high risk for mortality post placement of a PEG 
tube for the provision of long term enteral nutrition. South African specific literature, relating 
to the risk factors contributing to a high mortality rate post PEG placement, is lacking.  
This study aims to comment on patient mortality post placement of different types of enteral 
nutrition (NGT and PEG) as well as patients who were on oral intake as an alternative to PEG 
placement. The outcomes of this South African specific population will be compared to 
international outcomes to comment on the practices around enteral nutrition and its 
recommendation. This study also hopes to contribute to the area of appropriate patient 
selection for PEG placement, using a South African specific population, in order to guide 
clinicians who work with patients requiring enteral nutrition within a South African context.  
 






Aims and Objectives 
Three groups of adult participants with dysphagia were included in this study:  
a. Participants with multiple morbidities on enteral nutrition (NGT or PEG) 
placement  
b. Participants with multiple morbidities on oral palliative nutrition, instead of 
enteral nutrition 
c. Participants with a single morbidity on enteral nutrition 
 
The aim and objectives were: 
1. In patients with dysphagia managed by a Speech Language Therapist and by a 
medical Doctor, to  
a. Describe the number of cases of the different modes of nutritional intake (i.e. 
oral, enteral (NGT or PEG tube) or a combination of tube and oral) that were 
recommended 
b. Determine whether there were any significant differences in the mode of 
intake recommendations between the three groups  
c. Determine whether there were any significant differences in the timing of 
placement of enteral nutrition (i.e. NGT and PEG tube) after it had been 
recommended   
 NGT - from time of SLT recommendation to placement 
 PEG – from time of SLT assessment to recommendation  
 PEG- from time of medical Doctor recommendation to placement 
 
2. To compare the indications for a recommendation for short or long term enteral 
nutrition   
 
3. To compare mortality outcomes for long and short term enteral nutrition  
i) Pre placement  
ii) One day  





iii) One week  
iv) One month  
v) Three months  
vi) Six months post placement  
 
4. To compare survival times  
i) Across different modes of nutritional intake  
a. Short term enteral nutrition (NGT) 
b. Long term enteral nutrition (PEG) 
c. Oral palliative intake 
ii) Between single morbidity and multiple morbidities on long term enteral 
nutrition (PEG) 
 
5. Determine which of the following were risk factors for mortality post placement of 
short and long term enteral nutrition 
i) Increased age  
ii) Low blood albumin levels  
iii) Decreased quantity or absent intake of hydration and nutrition prior to 
placement of long term enteral nutrition (including interrupted feeds if NGT 
was the primary route of intake pre PEG placement) 
iv) Presence of two or more comorbidities  
v) Low body mass index at time of long term enteral nutrition placement 
 
Research Design 
Observational cohort study. 
An observational cohort design was used for this study (Mann, 2003). Use of this type of 
study design allows the researcher to comment on outcomes post exposure to a variable 
(Mann, 2003). The outcome being studied is mortality, and the variable which participants 
are exposed to is short and long term enteral nutrition. The main aim of a cohort study is to 
compare the risk of a certain outcome to exposure to a variable (Thadhani & Tonelli, 2006), 
such as the risk of mortality following exposure to the variable of enteral nutrition. The aims 





of this study include commenting on the outcome (mortality) of participants recommended 
for short and long term enteral nutrition, as well as determining the risk factors linked to 
mortality from exposure to short and long term enteral nutrition, which include increased age, 
decreased BMI, low albumin levels and comorbidities present. By using an observational 
cohort design the aims of the study are able to be fulfilled.   
This type of design is observational in nature as the researcher observes outcomes as they 
happen and is not involved in directly manipulating a variable, as would be the case in an 
experimental design (Mann, 2003). A cohort study is best suited to a situation where it is 
believed that there is an association between an outcome and exposure to a particular variable 
(Carlson & Morrison, 2009) but where ethics do not allow for direct exposure of a participant 
to that variable (Mann, 2003). This design is best suited to this study as it would be unethical 
to either expose or deliberately not expose a patient to different types of enteral nutrition, or 
to deprive a patient of enteral nutrition, in order to study the differing outcomes.  
There are two different types of cohort studies; retrospective and prospective. Retrospective 
cohort studies use data that has been collected previously for other reasons (Mann, 2003) and 
track a sample of people who have already been exposed to the variable. The aim is to 
document the experience of the participant from the time of exposure to a variable and follow 
them to note the outcomes that occur after exposure (Thadhani & Tonelli 2006). 
Retrospective data was included in this study because the researcher noted, anecdotally, that 
there were high mortality figures for patients recommended for, and fitted specifically with, 
long term enteral nutrition tubes.  
It was necessary to review folders from the past, when risk factors for mortality post 
placement were not considered by the SLT who was making recommendations for long term 
enteral nutrition. This was done in order to be able to compare patient care in these patients to 
that of patients who were managed after a change in approach of recommendation for PEG. 
At the time that the researcher began the study the new approach to management of PEG 
recommendations, where risk factors were considered, had already been implemented. For 
this reason, data for the participants with multiple morbidities, who were assessed and 
managed by an SLT, was collected retrospectively as their management had already taken 
place.  
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Using a retrospective approach the data available to the researcher was recorded in the past, 
leaving the researcher with no control over the available data, which may have missing parts 
(Song & Chung, 2010). Data may be incomplete or missing parts relating specifically to the 
study question because it was not originally collected with the aims of the study in mind 
(Mann, 2003; Thadhani & Tonelli 2006. Missing data was a difficulty experienced by the 
researcher in respect of missing data on patient weight and height. BMI data was absent, 
which affected the ability to comment on decreased BMI as a risk factor in participants with 
multiple morbidities who received PEG placement. 
Prospective cohort studies begin before the sample have been exposed to the variable and 
follow the sample for a period into the future, which allows for the researcher to make 
inferences about possible risk factors that may have affected outcome (Mann, 2003). It is 
possible to make similar comments with a retrospective cohort.  
The reason that a prospective aspect was included in this study was because the researcher 
wanted to include, into the analysis of outcomes post recommendation for enteral nutrition, a 
comparison of participants with a single morbidity who were receiving PEG on 
recommendation of a professional other than an SLT. These participants had not yet been 
exposed to a variable and had no outcome recorded in a hospital file, making a retrospective 
data collection approach impossible. For the retrospective part of this study, an aim of the 
research was to compare the outcomes of a group of participants who were managed under 
one approach to the recommendation of enteral nutrition to another group of participants who 
were managed under a different approach. Both of these approaches were implemented by the 
Speech Therapy Department at CHBAH for use when recommending patients for enteral 
nutrition. The two different approaches had already been, and were being used, at the time the 
research project was realised, so a retrospective approach was best suited to collect data for 
outcomes under these approaches. For the prospective part of this study, a further aim of the 
study was to compare these two participant groups who received care under two different 
approaches to a third group of participants who were not managed by an SLT using their 
approach for the recommendation of enteral nutrition, but were recommended for enteral 
nutrition by a medical Doctor with no consultation from an SLT.  
When using a prospective approach for data collection, the researcher waits for outcomes to 
occur, and for the disease processes to run their course, in order to make inferences (Song & 
Chung, 2010).  This can result in a lengthy and costly period of data collection as it is 





necessary to allow for an appropriate amount of time for outcomes to occur (Thadhani & 
Tonelli, 2006). There were no monetary implications as a result of waiting for follow up 
periods to occur, but the follow up period did delay the process of statistical analysis and 
write up of results.  
Validity and Reliability 
Internal Validity 
A study with high internal validity can state that changes seen in the results are as a result of 
exposure to a variable and not random or due to error (Carlson & Morrison, 2009). 
Components of internal validity that could be threatened in an observational study are 
selection bias, which includes loss to follow up, and confounding variables (Grimes & 
Schulz, 2002). 
Selection bias can occur if the participants chosen are not inherently similar; in this case 
outcomes noted could then be attributed to differences in the participant and not the variable 
being observed (Grimes & Schulz, 2002; Gurwitz et al., 2005). To exclude selection bias the 
researcher must include participants who all possess similar characteristics and who are most 
representative of the population being studied (Gurwitz et al., 2005). Yu and Tse (2012) note 
that selection bias from the researcher’s point of view is not a difficulty as long as inclusion 
and exclusion criteria are clearly noted and all eligible participants are included. This study 
included participants with similar attributes; they all had various medical conditions that 
required the placement of enteral nutrition. Differences were present between participants, 
but were necessary as these differences were variables whose effects were being observed as 
an outcome. These included variables such as age, medical condition, BMI and 
comorbidities, and type of enteral nutrition received.  
Loss to follow up can skew the results of a study if there are unequal drop outs between the 
groups within a study (Carlson & Morrison, 2009). Although retrospective data has already 
been documented, it is possible that a patient was not followed up in the medical file to the 
point at which the study aims require, because information was not originally documented 
with the study aims in mind and could therefore all relevant information for the study may 
not have been collected (Mann, 2003). The medical files accessed for this study documented 
all patient information and outcomes up until the point that the patient was discharged from 
hospital. After this point the patient was considered lost to follow up, and if mortality had not 





occurred at the point up until discharge from hospital then mortality as an outcome could not 
be analysed in these participants. This was the case for 8 participants with multiple 
morbidities who had a PEG placed. After their PEG placement they were discharged from 
hospital and it is unknown whether they survived or not. In a prospective study there is risk of 
loss to follow up and it is an important factor to consider how to successfully follow up on 
participants (Yu and Tse, 2012). This study followed up participants at regular intervals for 
up to six months. By making regular contact with participants in a study, the potential for loss 
to follow up is minimised (Hunt & White, 1998).  
Within a study, loss to follow up should not exceed 20% of the sample size or else it could 
affect results (Song & Chung, 2010). In this study 10% (2 participants, n=19) of the 
participants who had a single morbidity and were fitted with a PEG, were lost to follow up 
due to a disconnected phone when the researcher called at the three month follow up time.  
This is under the suggested percentage, so should not impact on results. In the cohort of 
participants with multiple morbidities who were fitted with a PEG, 66% (8 participants, 
n=12) were lost to follow up because they were discharged form hospital before an outcome 
was achieved. This is a large percentage of loss to follow up, and could affect results which is 
why it must be acknowledged as a major limitation of the study. The large loss to follow up 
in this cohort of participants occurred because the method of retrospective data collection was 
used. It was necessary to collect these participant’s data retrospectively in order to fulfil the 
aim of the study that looked at analysing the outcome of participants who were fitted with a 
PEG under one of the approaches for the recommendation of enteral nutrition, used by the 
Speech Therapy Department at CHBAH, which was an event that had already occurred at the 
time the study was realised.  
Many participants passed away during the data collection period, but death was an outcome 
being measured in this study. It was not considered as a loss to follow up but rather a result 
that was documented and analysed as part of the study aims.  
A study adheres to internal validity if there are no confounding variables, other than the 
independent variable, that could explain the outcomes observed (Polit & Beck, 2013; Singh, 
2007). A confounding variable is one that can be linked to both the outcome and the exposure 
(Thadhani & Tonelli, 2006).  





It is difficult to eliminate all confounding variables unless the study consists of a control 
group, in which case the researcher must comment on these variables in the write up of the 
results. Within this study, the patient’s underlying medical condition is a variable that is 
independent of the variable being measured (i.e., enteral nutrition), but it could affect 
outcome. Patients who receive the placement of long term enteral nutrition often die because 
of their underlying medical condition and not as a result of the PEG procedure (Poulose et al., 
2013). An aim of the study is to comment on whether placement of long term enteral 
nutrition affects mortality, but a patient’s medical condition could affect mortality as well, 
making it a confounding variable. This confounding variable has been noted by the researcher 
and will be considered appropriately when interpreting the results.  
 
External Validity 
External validity refers to whether the results of a study can be inferred onto a general 
population (Carlson & Morrison, 2009). A study with a sample that is not representative will 
lack external validity (Carlson & Morrison, 2009). The sample for this study comprised of 
participants who had dysphagia due to an underlying medical condition and as a result may 
have received short or long term enteral nutrition. This population could exist anywhere in 
the world which make the results of this study largely transferable to a greater population.  
Carlson and Morrison (2009) note that a common error leading to weak external validity is 
the inclusion of participants from only one institution or geographical area. This study 
collected data from only one hospital in Gauteng, South Africa. The hospital used, however, 
is a state hospital, and in South Africa 84% of the population access healthcare in state 
hospitals (Statistics South Africa, 2011). It is still uncertain though, whether the population 
accessing healthcare at CHBAH would be representative of the greater South African 
population, which could be noted as a limitation to the study. But the results of the study 
could still be applicable to patients in similar settings and who share similar characteristics to 










Intra-rater reliability was established by the researcher collecting data from the same patient 
hospital file at two different times and ensuring a 95% level of accuracy (Dixon & Pearce, 
2012). The patient hospital files were coded, by the researcher, by giving each patient a 
number, so that the researcher was blinded to the file and reviewed it one week later without 
access to the original data set. This process was repeated throughout the data collection 
period on every tenth file to ensure that the process of data collection remained the same 
throughout. After every ten files that the researcher reviewed, a break in collection would 
take place so that the researcher could go back and re-analyse the first of those ten files. It is 
noted that in most studies a random number of files for review are selected for reliability 
checks (Kimberlin & Winterstein, 2008; Yawn and Wollan, 2005). Every tenth file was 
reviewed and a 95.8% rate of reliability was achieved. Literature notes that 95% is an 
acceptable level of agreement for intra-rater reliability (Dixon & Pearce, 2012). The rate of 
agreement was calculated by doing a basic percentage calculation.  
Other forms of reliability were not applicable to this study, and have therefore not been 
discussed.   
Participants 
There were three groups of participants included in the study:  
Participants with multiple morbidities on enteral nutrition (NGT or PEG) placement  
Participants with multiple morbidities on oral palliative nutrition, instead of enteral nutrition 
Participants with a single morbidity on enteral nutrition 
 
Inclusion Criteria  
Any adult patient (over 18 years of age) with dysphagia who was assessed and managed as an 
in-patient at Chris Hani Baragwanath Academic Hospital (CHBAH) and recommended for 
enteral nutrition by an SLT or a medical Doctor or for oral palliative nutrition by an SLT.  
Exclusion Criteria  
There are no exclusion criteria for this study  
 






Convenience sampling, which was used in the study, is a non-random method of sampling 
where participants all possess certain qualities that the researcher wishes to look at to fulfil 
the purpose of the study (Babbie, 2012). When using this type of sampling method, the 
researcher cannot ensure that every member of a population has the chance of getting 
selected, which could affect external validity (Johnson & Christensen, 2010). In this study, 
convenience sampling was the best possible method to use for both the retrospective and 
prospective part of the study. Specific criteria had to be fulfilled in order for participants to be 
able to take part in the study, in which case random assignment would not have been feasible 
because the researcher had to select participants with dysphagia, who had multiple 
morbidities and who had been referred for enteral nutrition under both approaches used by 
the Speech Therapy Department as well as participants who had a single morbidity and were 
referred for enteral nutrition by a medical Doctor.  
Recruitment Strategy  
Recruitment does not apply to participants whose data was collected retrospectively. The 
researcher accessed the names of patients who fulfilled the study criteria from Speech 
Therapy records where after their hospital records were obtained from hospital archives for 
review.  
The names of patients who were referred for PEG placement by a medical Doctor were 
obtained from the gastrointestinal (GIT) department booking diary prior to the date of PEG 
insertion.  
Sample size 
It is important in the planning of a study to determine the required sample size to ensure that 
the study will be worthwhile and reveal significant results, but also for it to be feasible and 
financially viable (Lenth, 2001). A data collection period of six months was indicated by the 
researcher, as it was deemed a sufficient amount of time to obtain an adequate sample of 
participants. All patients who were assessed and managed for dysphagia by Speech Therapy 
within a six month period were included into the study. This was a total of 313 patients. Of 
those only 257 were recommended for short and long term enteral nutrition, and were 
therefore included in the final sample for the study in accordance to the inclusion criteria. 
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A power analysis was done using G*Power 3.1.9.2 to determine a sample size that would 
ensure a well powered study. It was determined that a sample size of 252 would be sufficient. 
The total sample size of the study was slightly bigger than the suggested sample size needed 
to ensure a sufficiently powered study. This ideal sample size identified includes the entire 
sample and not the individual cohorts of participants which were compared to each other.  
The small sample sizes in the individual cohorts could have affected the possibility of getting 
statistically significant results upon analysis. 
There were 212 participants with multiple morbidities who were referred for short of long 
term enteral nutrition by an SLT or a medical Doctor and 10 participants with a multiple 
morbidity who were referred for oral palliative nutrition by an SLT and 35 participants with a 
single morbidity who were recommended for a PEG by a medical Doctor. 
Participant description 
Table 2: Biographical information of participants 
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For participants with multiple morbidities on enteral nutrition the mean age was 59.2 years 
with a range of 18-94. For participants with multiple morbidities on oral palliative nutrition 
the mean age was 55.7 years with a range of 25-78. For participants with a single morbidity 
on enteral nutrition the mean age was 49.4 years with a range of 18-71.  
Table 3: Primary medical diagnosis of participants  




















































































Note: For participants with a single morbidity on enteral nutrition n=19 and not 35 because the remaining 16 participants who died 
before PEG placement were not included in the participant description because these participant files were never reviewed by the 





researcher. They were noted to have died in the ward register when the researcher went to the ward to gain consent from them before 
the procedure.   
 
 
The mean Charlson Index score for participants with multiple morbidities on enteral nutrition 
was 6.32 (range: 2-13) and the score for participants with multiple morbidities on oral 
palliative nutrition was 5.9 (range: 5-10).  
A breakdown of the medical conditions that appeared in each category is as follows:  
Neurological: CVA, neurosurgical, TBI, degenerative diseases (including dementia and 
motor neuron disorders) 
Trauma: Ingestion, external trauma to the head or body (gunshot wound or stab wound). 
Non communicable diseases: Head and neck cancer, malignancy.  
Infectious diseases: RVD encephalopathy, Tuberculosis meningitis (TBM), meningitis.   
Delirium and dehydration: No clear medical diagnosis given except for “delirium and 
dehydration”. 
Other: gastrointestinal disease, cardiac condition, sepsis, renal failure, hypoglycaemia, 
pancreatitis, anaemia, metabolic disorder. 
The categories were made with consideration of the South African Burden of Disease profile. 
There is some overlap where specific medical conditions could have fitted into two different 
categories, like RVD encephalopathy could be considered ‘neurological’ as well as an 
‘infectious disease’. The researcher wished to categorise the medical conditions as closely as 
possible to the South African Burden of Disease profile as this research was conducted in 
South Africa. 
Data Collection Tool 
An instrument was constructed by the researcher for the collection of data. The data 
collection tool was created on Epidata 3.1. (Appendix B) which allowed for all the relevant 





data for each participant to be recorded in a systematic manner. The tool comprised of 27 
fields to be completed for each participant. These fields included (1) basic patient information 
(hospital number, code to ensure anonymity, sex, age, weight and height), (2) medical 
information (primary and secondary medical condition, comorbidities, method of respiration), 
(3) dysphagia information (details of assessment, management and type of enteral nutrition 
recommended and medical professional who recommended it), (4) risks present pre 
placement (Decreased BMI, age over 60 years, presence of comorbidities, lack of nutrition 
and hydration pre placement) and (5) outcomes (mortality) after placement at different time 
frames (one day, one week, 30 days, three months and six months). The same tool was used 
to collect data for all three cohorts within the study. Each category contained a list of all 
possible options which were coded with numbers. The researcher would enter a single 
number into the cell next to the corresponding statement. For example under the category 
‘sex’ a number (1) would denote ‘male’ and a number (2) would denote ‘female’; if the 
participant was ‘male’ then the researcher would type a number (1) into the cell next to the 
category of ‘sex’. The coding of words with corresponding numbering made data entry easier 
as only a number needed to be entered each time as a pose to a whole word.  
Reliability and Validity of the Tool 
Reliability of a tool refers to the tool’s ability to consistently give the same result when used 
countless times (Goddard & Melville, 2004). The data for all three cohorts was entered using 
the same tool, by the same researcher. 
Content validity is determined by how well items on a test represent the construct that they 
are aiming to describe (Kimberlin & Winterstein, 2008). There is no statistical measure 
available to test content validity so it is often addressed by consulting professionals in the 
field of study (Kimberlin & Winterstein, 2008) or by a review of relevant literature. Construct 
validity refers to how accurately the tool measures the construct that it is meant to measure 
(Kimberlin & Winterstein, 2008). All evidence of content validity adds to proof of construct 
validity (Kimberlin & Winterstein, 2008). 
In this study content and construct validity were addressed by reviewing current literature in 
the field to ensure that all aspects included in the tool were based on current literature on 
PEG and adult dysphagia (see Table 4).  
 





Table 4: Data collection tool checklist  
Information Rationale Reference 
1.Biographical information  
1.1 Group Three cohorts were used in the 
study, a 1, 3 or 3 were entered to 
identify which cohort that 
participant belonged to  
 
1.2 Reference code Each participant had a reference 
code allocated to them in order to 
maintain confidentiality and 
anonymity 
Helsinki, 2013 
1.3 Sex This information was required in 




1.4 Date of Birth This was recorded in order to 
determine age, which was 
analysed as a risk factor for 
mortality as a study aim 
Abuksis et al., 2004; Blomberg et 
al., 2012; Grant et al., 1998; Ha & 
Hauge, 2003; Kobayashi et al., 
2002; Malmgren et al., 2011; Nair 
et al., 2000; Richter-Schrag et al,. 
2011; Smith et al., 2008 
1.5 Height and weight  This was recorded in order to 
calculate body mass index (BMI), 
which was analysed as a risk for 
mortality as a study aim 
Blomberg et al., 2012; Richter-
Schrag et al., 2011 
2. Primary medical conditions These medical conditions were 
included in the data collection 
tool as they are commonly 
associated with adult patients 
who have dysphagia and may 
require enteral nutrition 
 
2.1 Neurological Adults with neurological deficits 
commonly present with dysphagia 
and require enteral nutrition  
Bankhead et al., 2009;  
Blomberg et al., 2012; Donovan, 
Daniels, Edmiaston, Weinhardt, 
Summers & Mitchell, 2012; 
Gundogan et al., 2014;  
Holmes, 2011; Malmgren et al., 
2011; Rio et al., 2010; Sharp & 
Shega, 2009; 
Vivanti et al., 2009 
 
2.2 Trauma Adults who have experienced 
trauma to the head, neck and/or 
body may present with dysphagia 
and may require enteral nutrition. 
South Africa has a high level of 
interpersonal violence which 
makes this category important in a 
study using a South African 
population 
Harrison ,2009; Mokhosi & 
Grieve, 2004; Norman et al., 2007 
 
 
2.3 Non- communicable Disease The prevalence of non-
communicable disease is high in 
South Africa and contributes to 
Gundogan et al., 2014; Mayosi et 
al., 2009; Nguyen et al., 2006; 
Rimon, Kagansky & Levy, 2005; 





high rates of morbidity and 
mortality. Adults with these 
diseases will commonly present 
with dysphagia and will require 
enteral nutrition  
Wermker et al., 2012; Zhang et 
al., 2012 
2.4 Infectious Disease Infectious diseases are common in 
the South Africa context and can 
result in serious neurological 
fallout, which can cause 
dysphagia which will require a 
patient to receive enteral nutrition  
Levine et al., 2012; Rosenbloom, 
Sullivan & Pfefferbaum, 2010; 
Portegies & Rosenberg, 1998; 
Schneider, Bradshaw, Styen, 
Norman & Laubscher, 2009 
2.5 Delirium and Dehydration This was included in the list as it 
was noted by the researcher, when 
reviewing files in the pilot study, 
that it was a diagnosis commonly 
noted in hospital files as the 
primary diagnosis 
 
2.6 Other These included: Gastrointestinal 
disease, cardiac conditions, sepsis, 
renal failure, hypoglycaemia, 
pancreatitis, anaemia and 
metabolic disorders 
These were included in the list as 
“other” as they were noted upon 
review of the files to be the 
present as medical conditions, but 
did not fit into the pre-defined 
medical condition categories for 
the study  
 
3.General Medical Information  
3.1 RVD and TB status These diagnosis were noted under 
the infectious disease category if 
they are noted as the primary 
medical condition. But were also 
captured separately as important 
medical information within the 
South African context because of 
the high rate of infection in South 
Africa and the effect these 
comorbid diseases can have on a 
patients general health  
Bradshaw et al., 2002; Brew, 
Crowe, Landay, Cysique & 
Guillemin, 2009 
3.2 Comorbidities  These included commonly noted 
comorbidities in hospital files 
such as: diabetes, respiratory 
disease, hypertension, renal failure 
and hemiparesis 
Kobayashi et al., 2002; Smith et 
al., 2008; Quan, et al., 2005; Zopf, 
2011 
3.3 Patient State at Assessment  This was important to include as it 
provided information on why 
enteral nutrition may have been 
indicated prior to an assessment 
by an SLT. Ie. In the case a patient 
was unconscious at the time of 
Lloyd & Powell-Tuck, 2004; 
Stroud et al., 2003  
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referral to the SLT 
3.4 Albumin level This was recorded as it was 
information which was analysed 
as a risk for mortality as a study 
aim 
Blomberg et al., 2011; Janes et al., 
2005; Nair et al., 2000; Lang et 
al., 2004 
4. Dysphagia and Enteral Nutrition Information
4.1 The type of dysphagia Adult patients can present with 
difficulties in any phase of the 
swallow which will determine the 
extent of nutritional intake they 
are capable of and the safety of 
this intake. The type of dysphagia 
(oral phase, pharyngeal phase or 
oesophageal phase) is important to 
note as it can inform decisions 
about the method of intake (oral, 
short or long term enteral 
nutrition). The type of dysphagia 
that a participant had was 
determined by the SLT after a 
clinical (bedside) evaluation and 
documented in the hospital file. A 
diagnosis of oesophageal phase 
dysphagia was documented if 
there was a confirmed diagnosis in 
the hospital file based on an 
objective study.   
Blackwell & Littlejohns, 2010; 
Erdil et al., 2005; Holmes, 2011; 
Seidl, Nusser-Muller-Busch, 
Westhofen & Ernst, 2008; Via & 
Mechanick, 2013 
4.2 Methods of intake (current, 
post assessment and/or treatment 
by an SLT)  
These categories were included to 
identify the method of intake 
participants were recommended 
for before an SLT assessment and 
after assessment and/or treatment. 
The information can provide 
details about the use of enteral 
nutrition upon admission before 
an SLT has assessed, and the 
amount and type of enteral 
nutrition recommended by an SLT 
Blackwell & Littlejohns, 2010; 
Erdil et al., 2005; Holmes, 2011; 
Seidl, Nusser-Muller-Busch, 
Westhofen & Ernst, 2008; Via & 
Mechanick, 2013 
4.3 Timing of recommendation for 
enteral nutrition (by an SLT and a 
medical Doctor) 
The timing of the recommendation 
and placement of enteral nutrition 
was included as it was required to 
analyse as a risk factor for 
mortality as a study aim  
Abuksis et al., 2004; Prosser-
Loose & Paterson, 2006; Westaby 
et al., 2010 
4.4 Recommendation made by 
another professional  
This information was recorded as 
one of the study aims was to 
compare the differences in 
recommendation for enteral 
nutrition between SLTs and 
medical Doctors 
Stroud et al., 2003; Tanswell et 
al., 2007 
4.5 Delay in or failure of 
placement of enteral nutrition post 
recommendation  
Delays in the placement of enteral 
nutrition when needed can 
exacerbate malnutrition and 
increase morbidity and mortality. 
Kim et al., 2012; MacDougall, 
2010 






4.6  Interrupted feeds on short 
term enteral nutrition 
 
The delays or interruptions in 
feeding are important to note as 
they can affect survival  
Beavan et al., 2010; Kim et al., 
2012; MacDougall, 2010 
5.Outcomes  It was important to capture 
outcomes for patients who 
demised on oral intake, short 
term enteral nutrition and long 
term enteral nutrition or before 
the placement of enteral 
nutrition in different places as 
these patients survival rates 
were compared in analysis  
 
5.1 Final outcome if on oral feeds  Patients whose outcome was 
recorded here included those who 
had dysphagia and who would 
have been on enteral nutrition at 
some point, but whom were 
discharged from hospital or who 









5.2  Demised before assessment 
  
This was recorded in order to 
fulfil the study aims 
 
 
5.3 Demised before placement of 
short term enteral nutrition  
 
This was recorded in order to 
fulfil the study aims 
 
5.4 Demised before placement of 
long term enteral nutrition  
 
This was recorded in order to 
fulfil the study aims 
 
5.5 Demised after placement 
(Different time points given as 1 
day, 1 week, 1 month, 3 months 
and 6 months)  
This was recorded in order to 
fulfil the study aims 
(Codner, 2012; Gomes et al., 
2012; Vassilyadi et al., 2013 
 
After construction, the tool was reviewed by an SLT who had been working in the field of 
adult dysphagia within the Speech Therapy Department at CHBAH for four years. The SLT 
agreed with the elements that had been included in the tool based on her knowledge in the 
area, which ensured face validity of the tool.  
Procedure 
Following approval of the study by The University of Cape Town Faculty of Health Sciences 
Human Research Ethics Committee (HREC REF: 503/2013) (Appendix C), approval was 
requested and obtained from the Internal Ethics Review Board at CHBAH (Appendix E) and 
from the Heads of Departments that were to be involved in the study (Speech Therapy and 
Gastroenterology) (Appendices F and G).  A pilot study was then conducted, after which 





changes were made to the data collection tool before data collection for the main study 
commenced.   
Pilot Study 
A pilot study is done before the main study is started in order to test the feasibility of the 
study, the instruments that are going to be used to collect data in the main study and the basic 
procedures that have been planned for the main study (Thabane et al., 2010; Van 
Teijlingen & Hundley, 2004). Conducting a pilot study is important as it allows the 
researcher to replicate the main study on a smaller scale so that any difficulties in recruitment 
of participants, data collection, and data analysis can be identified and changed accordingly 
(Van Teijlingen & Hundley, 2004) which will ensure that processes in the main study run 
without difficulty.  
The pilot study was done after the completion of the data collection tool in order to test its 
feasibility. Johanson and Brooks (2009) suggest a basic number of 12 participants per group 
where the study is expected to have three groups of participants. In line with 
recommendations from the literature, 36 files were reviewed by the researcher. 
Minor changes were made to the data collection tool after the completion of the pilot study, 
which included: 
1. Addition of medical conditions which had previously been left off the existing list. 
The additions to the list reduced the frequency of the non-specific “other” being 
selected in the drop down list during data collection  
2. Addition of a joint comorbidity of “hypertension and diabetes” to the list of 
comorbidities as these were noted to co-occur frequently in the review of files in the 
pilot study.  
 
After the data for the pilot study had been collected, it was noted that there were areas that 
had a lot of missing or incomplete data, such as the weight and height of participants. It was 
decided that although there were many blanks in this area the section would not be omitted 
from the tool that would be used for the main research project. The reason for this was that 
the same tool would be used to collect data for participants with a single morbidity who were 





referred for PEG by a medical Doctor, where there would be no missing data for weight and 
height due to the prospective nature of data collection for this cohort. 
 
The data from the pilot study was not analysed by a statistician as the statistician indicated 
that a complete set of data was preferable to start analysis. The researcher discussed the pilot 
data with the same statistician who would analyse the data at the end of the study and 
deliberated the data collection tool. The researcher and the statistician both agreed that the 
tool contained the relevant questions to allow for the researcher to capture data that could be 
analysed to fulfil the aims of the study.   
 
Data Collection 
Data collection for the study took place over a period of time which included data collection 
of both retrospective and prospective data. Collection of data for participants with multiple 
morbidities who were assessed and managed by Speech Therapy involved retrospective 
review of medical folders. During this period, the researcher worked within the archive 
department at CHBAH as hospital policy does not allow for hospital files to be removed from 
the property. The researcher reviewed each file and entered data onto the electronic Epidata 
spread sheet for each participant prior to reviewing the folder for the next participant. Each 
participant’s name and hospital number was written into a code book and assigned a number 
prior to reviewing the folder. The process of replacing a patient name and hospital number 
with a number ensured anonymity of information once it was collected and entered into the 
electronic spreadsheet. The data had to be made anonymous to uphold patient confidentiality 
because it was going to be seen by the statistician in the data analysis phase. The codebook 
was kept by the researcher in a locked cupboard and was never left in the same place as the 
laptop containing the patient data to ensure confidentiality (Babbie, 2012).  
 
A diary was kept by the researcher, with notes about medical conditions and how each one 
was classified, so that data collection was uniform throughout as it was done over a period of 
two months. For example, a patient who had sustained a traumatic brain injury (TBI) and had 
undergone neurosurgery as a result, would have their primary medical condition noted as 
“TBI” and their secondary medical condition noted as “neurosurgical”. Vassar and Holzmann 
(2013) noted that failure to create and utilise a standard procedure as set out in a manual or 





diary to ensure consistent method of data abstraction is one of the main methodological 
threats in retrospective folder reviews.  
 
In the period of prospective data collection, for participants with a single morbidity who were 
referred for PEG placement by a medical Doctor, the researcher obtained informed consent 
from participants prior to review of their medical folder. The researcher used the information, 
as set out on the informed consent form (Appendix H), to introduce herself to the patient, to 
introduce the study, and to give the patient information on the study and their role should 
they choose to consent to take part. The patient was given the opportunity to ask any 
questions and was then asked to sign the consent form. Thereafter the researcher reviewed the 
participant file to obtain the relevant information needed in accordance with the data 
collection tool.  
If the participant was unable to sign consent themselves, a different form (Appendix I) was 
used. It was addressed to the participant’s legal proxy to sign on their behalf. This form had 
the same information about the study as the form for participants who were able to sign for 
themselves. It also gave the legal proxy the opportunity to ask questions and decide whether 
they would consent for their family member to take part in the study. The legal proxy was 
approached by the researcher during visiting hours at the hospital to discuss the study and ask 
for consent on behalf of the participant.  
The consent form was written by the researcher in English. Considering that there are a 
multitude of languages spoken by people in South Africa, with no specific language 
dominating the Gauteng province (Statistics South Africa; 2011), the consent form was not 
physically translated but rather was to be translated into the chosen language when verbally 
administered, if necessary. Due to the lack of access to translators within the government 
setting, therapists often rely on trained Speech Therapy assistants to help translate during 
assessment and therapy sessions. This is not ideal, and according to The Committee for 
Human Research at the University of California (2003), a qualified translator should be used. 
Trained SLT assistants, who spoke a variety of languages, were available to translate the 
consent form if it were required. During the course of this study, all participants or their 
proxies were able to understand and communicate in English”.  






Participants who were referred for enteral nutrition by a medical Doctor were in-patients at 
CHBAH at the time of data collection. The researcher located the patient within the ward 
before the scheduled date of PEG insertion, received informed consent and then reviewed the 
medical folder.  After PEG insertion the researcher followed up on the participant at the 
specified periods (one day, one week, 30 days, three months and six months). Follow up was 
within the ward if the participant was still an in-patient or telephonically if the participant had 
been discharged from CHBAH. Follow up data collection for this group of participants was 
recorded by the researcher on a hardcopy of the electronic spreadsheet as this was more 
feasible than carrying a laptop around to the hospital wards. Once data was complete for one 
participant (if the specified follow up time frame was over, or if the participant had demised 
before the end of the follow up period) the researcher entered the information onto the 
electronic spreadsheet in the same manner as data of other participants.  
All data was entered into the electronic spreadsheet by one researcher. Every care was taken 
to ensure accurate data capturing that was free from human error. The Epidata programme 
used by the researcher to collect the data enables checks to be put into place to ensure that it 
is mostly free of human error when it is entered. These checks consisted of double inputting 
of data which the program automatically checked for differences in input, ensuring accurate 
input of data by the researcher. Human error is possible when inputting data from a file onto a 
computer, but with this method of data input human error would be checked by the computer 
program. The researcher reviewed each file twice within the same period of time and input 
the data into the programme immediately. If data inserted the second time differed from the 
data inserted the first time then the programme would alert the researcher to the discrepancy. 
This would then be reviewed and corrected by the researcher. These checks resulted in 
accurate input of data throughout the collection period. 
Data inserted into the tool was done using numbers, with each number reflecting a word or 
phrase. A key code was made to document the numbers and their corresponding words or 
phrases. For example a list of possible medical conditions was coded by the researcher with 
traumatic brain injury (TBI) as number 1. When the researcher input data into the tool the 
number 1 was used to reflect a participant with a TBI. This coding made input quicker as 
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whole words or phrases did not need to be typed in each time. The tool aimed to record data 
systematically from pre-existing records in order to fulfil the aims of the study. 
Data Management 
Although all data was entered onto one spreadsheet concurrently, each data set was coded as 
either group one, two or three to make individual analysis of groups and comparisons 
between groups easy. Group one referred to participants with multiple morbidities who were 
referred for enteral nutrition. Group two referred to the participants with multiple morbidities 
who were placed on oral palliative nutrition. Group three referred to participants with a single 
morbidity who were referred for enteral nutrition.  
When reviewing the file and noting the method of intake that was recommended, a 
nasogastric tube (NGT) could have been recommended either by an SLT, a medical Doctor or 
both. The professional who recommended the method of intake (NGT/percutaneous 
endoscopic gastrostomy (PEG)/oral) first in the patient file was the professional who was 
recorded as having made the recommendation. 
Data Analysis 
Difficulties arose during the period of data collection for participants whose information was 
collected retrospectively, with regard to missing data. Missing or incomplete data was 
omitted from the analysis of that section and the sample size was adjusted accordingly for 
analysis. This method was in accordance with Howell (2008) who suggests that in an 
observational study, missing data can be dealt with by using ‘casewise deletion’ where all 
cases that have missing data are dropped from the final analysis.  
Missing data included patient albumin levels which are not always routinely done for every 
patient admitted to CHBAH. Within hospital records at CHBAH weight is primarily recorded 
by the dietician at their first patient consult, but not all patients are seen by a dietician. When 
a consult by the dietician was recorded in the hospital file, weight was recorded as an 
estimated weight with no height recorded.  





In acute settings where a patient is immobile or unconscious it can be impossible to measure 
weight and height accurately (Ferro-Luzzi & James, 1996). It is suggested in literature that 
other methods for commenting on nutritional status, such as a measurement of upper arm 
circumference which can be used in cases where weighing is not possible (Ferro-Luzzi & 
James, 1996). No such data was recorded in the hospital files reviewed by the researcher. The 
information on nutritional status that was recorded by the dietician in the hospital file made it 
impossible to calculate body mass index in order to comment on nutritional status. The 
researcher consulted with a registered dietician from The University of Cape Town (F. 
Herrmann, personal communication, June 9, 2013) and it was noted that “estimated weight” 
held no relevance and could not be used to comment on as a reliable measure. BMI as a 
possible risk factor for poor outcome could not, therefore, be included in the groups where 
data was collected retrospectively. Weight and height detail was collected for every patient 
whose data was collected prospectively as the researcher had direct contact with these 
participants and BMI could be calculated in this group.  
Data collection for participants who were assessed and managed by Speech Therapy ended at 
the point that their hospital stay ended or at the point of demise. Of these participants, those 
who had placement of a PEG were not followed up on past the point of discharge as they fell 
into the group of retrospective data collection.  
Participants whose data was collected prospectively were followed up to the point of 6 
months or until demise if it occurred within the 6 month period. Every effort was made to 
contact participants for follow up telephonically.  In one case a patient could not be contacted 
as, when the researcher called to follow up, the number taken down at the start of data 
collection was no longer in service. This participants’ data was analysed up until the point of 
loss to follow up and data after which it was left out of the analysis and noted to be a loss to 
follow up.  
Statistical Analysis 
Descriptive statistics were used for categorical variables (sex and primary medical condition) 
and were represented as frequencies and percentages. For continuous variables (age, 
comorbidities present, dysphagia present, respiratory status, albumin levels, weight and 





height) descriptive statistics were presented using mean ± standard deviation or as a median 
value with inclusion of the range.  
To determine whether the relationships between two categorical variables were statistically 
significant, the chi-square test of independence was carried out. Alpha was set at 0.05 
significance level for all analyses.   
Where there are continuous variables, chi-square cannot be used so a t-test is used to 
determine significance (Lind, Marchal & Wathen, 2005). A t-test is sufficient where there is 
an inclusion of only two groups for analysis. This included analysis of comparisons between 
NGT and PEG as well as a comparison of survival between participants fitted with an NGT 1 
day after recommendation versus anytime over 1 day.  
Kaplan Meier (KM) graphs measure the number of participants that survive for a certain 
amount of time after a specific type of intervention (Goel, Khanna, &, Kishore, 2010) and in 
this study were used to explore participant survival after placement of enteral nutrition, 
between the 3 cohorts included in the study. A non-parametric statistical test called a logrank 
test was done for each Kaplan Meier graph to compare the graphs and determine if survival 
rates were different, as this cannot be determined correctly just by looking at the plots on the 
graph (Bewick, Cheek, & Ball, 2004; Walters, 2009). A logrank test can determine if there is 
a difference in survival between two groups but it cannot identify any variables that may have 
caused the difference (Bewick et al., 2004).  
Cox regression hazard analysis assessed the magnitude of risk of death (Bewick et al., 2009) 
according to the key exposure variables, such as: age, time of placement, nutritional status at 
time of placement and comorbidities present, first exploring one factor at a time and then 
doing a multivariate/adjusted analysis. The analysis produced an estimated hazard ratio or 
‘risk of death’ according to a participant’s exposure to a certain variable. A positive 
regression coefficient highlights a positive link between that variable and the hazard (risk of 
death) (Bewick et al., 2009). All hazard coefficients should be tested for significance, as a 
significant result will alert the researcher to the fact that in the study, the hazard had a direct 
effect on death, and was not just a risk. A non-significant p value will reveal that the variable 
placed a participant at risk of death (if accompanied by a positive regression coefficient), but 
that the variable was not an independent variable resulting in mortality.  





Statistical analysis was performed using the Statistical Package for the Social Sciences 
(SPSS) version 19.0 for Windows. 
Ethical Considerations  
This study will be conducted in accordance with Helsinki 2013. 
 
Ethics approval was obtained from the University of Cape Town’s Faculty of Health Sciences 
Human Research Ethics Committee before commencement of the study (Appendix C). 
 
Autonomy: In research ethics, autonomy refers to a participant’s right to make an informed 
decision about whether they want to consent to take part in a study and their right to 
withdraw from the study at any point (World Medical Association Declaration of Helsinki, 
2013). In this study, information about the study was provided to each participant and they 
were given a choice of whether or not they wanted to sign consent to take part. Implied 
consent was obtained from all participants whose information was collected prospectively 
(Appendices H and I). Participants whose data was collected retrospectively were not directly 
involved in the study at the time of data collection, so implied consent was not obtained. 
Rather consent from the hospital ethics board to review medical files of patients who had 
previously been treated at CHBAH was obtained (Appendix E). 
Confidentiality: All data was stored on a laptop that was password protected and kept in a 
safe, locked room when not in use. Patient names were not recorded but rather coded at the 
time of data collection to ensure confidentiality. Coding also aided in the blinding process to 
assess reliability. Coding was done by assigning each patient with a number that was used 
throughout the study process. At the end of the data collection period all identifying 
information was destroyed so that no link could be made between codes and patient names.  
Beneficence: Participants were not directly involved in this study and were not expected to 
take part in any kind of testing. Participants who were involved in the study did not benefit 
from this study but the results could be used to benefit others who receive enteral nutrition in 
the future. 





Non-maleficence: This refers to the need to do no harm (World Medical Association 
Declaration of Helsinki, 2013). Participants whose data was collected prospectively were not 
required to do anything extraordinary in order to be included in the study, and therefore were 
not at any risk of harm. The retrospective aspect of the study meant that data was collected 
via a folder review and therefore posed no harm to participants.  
Justice: All participants who met the inclusion criteria had an equal chance of being included 
in the study. Those who did not meet the criteria were not at a disadvantage for not having 
been included as no direct benefits were experienced by study participants anyway. The 
benefits of the study will be equally applicable to a similar population from which the 

















Results of the study are reported according to the study aims.  
1. Mode of intake 
Different modes of intake that were recommended for participants in the study by both an 








Short Term Enteral Nutrition  
In the population of patients with multiple morbidities (n=212) an NGT was recommended 
most frequently by an SLT.  The difference between the number of NGTs recommended by 
an SLT and a medical Doctor is significant (Chi-square; p=.003), with an SLT recommending 
more NGTs than a medical Doctor. 
Placement of NGT Post Recommendation  
Out of those patients recommended for NGT placement (n=156), 71.1% (n=110) of patients 
had an NGT placed after recommendation. There was a significant difference (Chi-square; 
p<.001) between those who had an NGT placed after recommendation by a Speech Therapist 
(61.1% n=62) versus a medical Doctor (9.2% n=5) with more placements occurring after 
recommendation by a Speech Therapist.  
 
Table 5: Mode of intake recommended by a 











































Risks and outcomes for enteral nutrition among adults with dysphagia at a tertiary level hospital in 
South Africa 
59 
Long Term Enteral Nutrition 
In the population of participants with multiple morbidities (n=212), a PEG was recommended 
100% of the time by an SLT. In the population of patients with a single morbidity (n=35), a 
PEG was recommended 100% of the time by a medical Doctor. In the total study sample 
(N=257) the percentage of patients recommended for PEG by a Speech Therapist was 61.5% 
(n=56) and by a medical Doctor it was 14.1% (n=35). There is a significant difference in the 
professional who recommended PEG placement (Chi-square; p=.050).  
Placement of PEG Post Recommendation 
A significantly greater number of PEGs were placed in participants with a single morbidity 
than were placed for participants who had multiple morbidities (Chi-square; p=.001)  
Table 6 depicts the reasons why a PEG was not fitted after it was recommended in 
participants with multiple morbidities and a single morbidity.   
In the group of patients with multiple comorbidities a significantly greater (Chi-square; 
p=.001) number of patients (50%; n=56) died before the placement of PEG than those with a 
single morbidity (17.1%; n=35). This result highlights the importance of considering the 
Table 6: Number of PEG tubes not placed after recommendation in participants with multiple 
morbidities versus a single morbidity  
Patients with single morbidity who 
were recommended for PEG by a 
medical Doctor 
n=35 
Patients with multiple morbidities 
who were recommended for PEG by a 
Speech Therapist 
n=56 
PEG placed 19 12 
PEG not placed 16 44 
Reasons PEG was not placed 
Died before placement 6 28 
No longer needed PEG at time of 
insertion  
2   2 
Unknown reason 2 14 
Discharged from hospital before 
placement 
2 -- 
Refused procedure 4 -- 





number of morbidities that a patient presents with before making a recommendation for PEG, 
as multiple morbidities place a patient at great risk of mortality.   
Timing of placement of enteral nutrition post recommendation  
The time lapse between enteral nutrition recommendation and placement in single and 
multiple morbidities and how it related to mortality post placement of enteral nutrition is 
depicted in Table 7. 
 
The average time it took for an NGT to be placed after recommendation was made was great, 
with the largest majority of participants waiting 2 days for placement. There was no statistical 
Table 7: The time lapse from assessment of a patient to the recommendations for enteral nutrition to the 
placement of it 
 Time to placement (in days) Significance (p value) 
(t-test) 
NGT in participants with 
multiple morbidities: from time 
of SLT recommendation to 
placement 
 
Mean ± STD 2.74 ± 2.13 
(median: 2; range: 0-8; mode: 2). 
 
p=.189 
NGT in participants with 
multiple morbidities: from time 
of Dr recommendation to 
placement  
 
Data not available from patient files. *A 
Dr will not record recommendation of 
an NGT but rather just place it 
 
 
PEG in participants with 
multiple morbidities: from time 
of assessment of patient by 
Speech Therapist to 
recommendation for PEG 
 
Mean ± STD 4.78 ± 3.373 
(median: 4; range: 0-9; mode: 1) 
Note: Mortality data post 
placement of a PEG was 
only available for 3 
patients. Insufficient sample 
size to conduct an analysis. 
PEG in participants with a 
single morbidity: from time of 
Dr recommendation for PEG to 
placement  
Mean ± STD 13.8 ± 9.579 
(median: 10; range: 0-39; mode: 9) 
 
p=.221 





significance linking mortality to the time lapse in placement of an NGT (p=.189). An SLT 
would recommend a PEG an average of 4.78 days after first assessing a patient with multiple 
morbidities, with the largest majority of participants with multiple morbidities being 
recommended for a PEG 1 day post assessment. In participants with a single morbidity there 
was a relatively short time lapse from when a PEG was recommended to when it was placed, 
with no statistical significance linking the time lapse to mortality post placement.   
 
2.Indications for Enteral Nutrition  
The presence of dysphagia  
Inability to achieve adequate nutrition and hydration orally due to dysphagia, or refusal of 
hydration and nutrition orally, resulted in the recommendation for enteral nutrition.  
 
Figure 1: Indications for the recommendation of enteral nutrition in single and multiple morbidities   






























Indications for the recommendation of enteral nutrition 
(n=247) 
Participants with multiple morbidites (n=212) Participants with a single morbidity (n=35)





Enteral nutrition could have been recommended as a result of a medical condition that 
resulted in the need for it. Table 8 notes the presence of various medical conditions that 















NGTs were recommended most frequently for participants who had a neurological deficit. 
There was an equal number of recommendations made for an NGT in participants with 
infectious and non-communicable diseases. The most common medical condition requiring a 
PEG was non communicable diseases, followed by neurological deficits and trauma.  
 
3.Mortality rate of participants recommended for NGT and PEG  
Mortality rates of participants recommended for short and long term enteral nutrition were 
compared at different points in time after recommendation or placement was made and are 





Table 8: Primary medical condition of participants who 











Neurological  114 (73.1) 23 (25.3) 
   
Trauma 4 (2.6) 19 (20.9) 




13 (8.3) 28 (30.8) 
   
Infectious 
diseases 
13 (8.3) 2 (3) 
   
Delirium and 
dehydration 
3 (1.9) 0 
   
Other 9 (5.8) 2 (3) 










The greatest rate of morality occurred at the point pre placement of enteral nutrition, the 
highest rate being pre PEG placement compared to pre NGT placement. The greatest overall 
percentage of mortality was noted in participants who were recommended for and/or fitted 
with an NGT versus PEG.  
 
4.1 Survival times across modalities  
a) Short term enteral nutrition (NGT)  
Of the patients who were recommended for an NGT, 80.8% (n=156) died at some point 
during the study period. The greatest majority of these participants died within 1 month of 
insertion. Survival time differed between participants who had an NGT placed after it was 
recommended and those who did not. The median survival (range: 0-75) for participants who 
had an NGT placed was significantly longer (23 days) compared with 8 days for participants 
Table 9: Mortality rates of participants with multiple morbidities and a single morbidity who were 











































 178 (72.1) 
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who did not have an NGT placed. A log-rank test confirmed that difference in survival 
between participants who were fitted with an NGT post recommendation had significantly 
greater survival than those who were not fitted with an NGT post recommendation (p=.013; 
Figure 2).  
       NGT placed  
after recommendation 
 NGT not placed after 
 recommendation 
    Time (days to death) 
No. of subjects   Event  Censored   Median survival time (95%; CL) 
NGT placed after recommendation    65   44.6% (29)   55.4% (36)  23 (10.729    35.271) 
NGT not placed after recommendation   28    46.4% (42)    53.6% (15)     8 (1.865     14.135) 
Figure 2: Kaplan Meier graph showing survival of patients who were fitted with an NGT post recommendation 
(green) and those not fitted post recommendation (blue).  
Note: The number of subjects refers to the total number of subjects included in the analysis (event + censored). 
Event refers to the number of participants for whom there was complete data of all variables needed to conduct 
the analysis. Censored (indicated by small vertical dashes across the curves) refers to the number of participants 
for whom there was incomplete data at one of the points in time and could therefore not be analysed in full.  
b) Long term enteral nutrition (PEG)
Of the 91 participants who were referred for PEG placement, 31 PEGs were placed. Of these 
31 participants, 1 participant survived throughout the study period of six months and 12 were 
















Log rank p=.013 





participants with both multiple morbidities and a single morbidity, who had a PEG placed in 








Comparison of survival time between NGT and PEG (both multiple morbidities and 
single morbidity) 
 
                        Patients with PEG in situ





     
 
 
        Time (days to death) 
   
    No. of subjects         Event      Censored             Median survival time (95%; CL) 
Patients with PEG in situ           18               100% (18)      0% (0)          30 (0.000       69.499) 
Patients with NGT in situ          86                    40.7% (35)         59.3% (51)                 20 (9.640       30.360) 
Table 10: Mortality rate post PEG placement of 
participants with single and multiple morbidities 
Mortality rates n= 18  
n (%) 
1 day 0 
1 week 2 (11.1)  
1 month 7 (13.2) 
3 months 5 (27.8) 
















Log rank p= .043 





Figure 3: Kaplan Meier graph comparing survival of patients fitted with an NGT (blue) or a PEG (green).  
Note: The number of subjects refers to the total number of subjects included in the analysis (event + censored). 
Event refers to the number of participants for whom there was complete data of all variables needed to conduct 
the analysis. Censored (indicated by small vertical dashes across the curves) refers to the number of participants 
for whom there was incomplete data at one of the points in time and could therefore not be analysed in full 
Survival time differed between patients who had a PEG placed and those who had an NGT 
placed. The median survival for patients who had a PEG placed was significantly greater at 
30 days compared with 20 days for patients who had an NGT placed (log rank test; p= .043; 
Figure 3). 
 
c) Oral palliative nutrition  
The median survival (range: 2-19) for patients who were placed on oral palliative nutrition, 
instead of being recommended for enteral nutrition, was 19 days. When compared to the 
survival times of participants who were on enteral nutrition the log rank statistic showed no 
significant difference (p=.737; Table 11). 
 
 
Note: The number of subjects refers to the total number of subjects included in the analysis (event + censored). 
Event refers to the number of participants for whom there was complete data of all variables needed to conduct 
Table 11: Comparison of survival times between participants with multiple morbidities and a single 
morbidity who were received a PEG and participants who were placed on oral palliative nutrition  











fitted with PEG        
          3                  100% (3)                         0% (0)          24 (NA) 
 
Participants                                  
on oral palliative 
nutrition   
 
          
 
           10 
 
 
40% (4)       
 
 
       60% (6) 
 
 
19 (0.000  45.799) 





the analysis. Censored (indicated by small vertical dashes across the curves) refers to the number of participants 
for whom there was incomplete data at one of the points in time and could therefore not be analysed in full.  
When ‘NA’ is reported for the confidence level it means that horizontal line did not intersect with the 
confidence interval for that data set.  
 
All participants who were placed on oral palliative nutrition were followed up to the point 
that they were discharged form hospital. At the point of discharge from hospital, 6 
participants were still alive. In this same time period, 4 participants had died (allowing for 
their data to be used in a survival analysis).  Participants who demised on oral palliative 
nutrition survived for a median of 19 days, compared to a survival rate of 24 days for patients 
with multiple morbidities who were fitted with a PEG and 54 days for patients with a single 
morbidity who were fitted with a PEG.  
 
4.2) Multiple morbidities with PEG versus single morbidity with PEG 
 
                Patients in with single morbidity 
                   fitted with PEG  
                            Patients with multiple morbidities   
                   morbidities fitted with 






     Time (days to death)  
     No. of subjects         Event      Censored             Median survival time (95%; CL) 
Patients with a single morbidity fitted with PEG        15                100% (15)   0% (0)   54 (17.392     90.608) 
















Log rank p= .038 





Figure 4: Kaplan Meier graph comparing survival of patients with multiple morbidities who were fitted with a 
PEG (blue) and those with a single morbidity who were fitted with a PEG (green).  
Note: The number of subjects refers to the total number of subjects included in the analysis (event + censored). 
Event refers to the number of participants for whom there was complete data of all variables needed to conduct 
the analysis. Censored (indicated by small vertical dashes across the curves) refers to the number of participants 
for whom there was incomplete data at one of the points in time and could therefore not be analysed in full.  
The median survival post PEG placement for patients with a single morbidity was  
significantly longer (54 days) compared to the survival of patients with multiple morbidities 
which was 24 days (log rank test; p=.038; Figure 4). Due to the retrospective nature of data 
collection for participants with multiple morbidities who had a PEG placed, complete follow 
up data was only available for 3 participants. One should interpret this Figure 4 with caution 
because of the small cohort used, which could cause an unreliable representation of survival. 
 
 
5.Risk factors for mortality post placement of short and long term enteral nutrition   
A risk factor analysis was conducted using Cox regression hazard analysis. The risk factor 
analysis included all patients who were recommended for short and/or long term enteral 
nutrition.  
When interpreting the results of a Cox regression hazard analysis, it is important to analyse 
the hazard ratio and the p-value which will indicate the significance level of this figure. A 
hazard ratio can be a negative or a positive number. If it is a negative number it means that 
the variable had no effect on the outcome, and if it is a positive number it means that the 
variable did have some kind of effect on the outcome. In the study, all hazard ratio figures 
had a positive value, which means that many variables (increased age, decreased BMI, 
decreased albumin level and a high Charlson score) placed a participant at a greater risk of 
mortality.  
A p-value that is significant, alongside a positive hazard ratio, means that the variable 
independently influences the outcome. In this case none of the p-values that accompanied the 
hazard ratios were significant (p>0.05). This indicates that no single variable (increased age, 
decreased BMI, decreased albumin level and a high Charlson score) could be attributed to 
having independently affected survival rate. There may have been other factors that 
confounded the outcome.  





The researcher can interpret the results by noting that all variables placed the participant at a 
certain risk of mortality, but none were an independent contributor to mortality. 
 
Risks for mortality post placement of NGT versus PEG in participants with multiple 
and single morbidity   
Table 12 depicts the variables that were positively linked to a greater risk of mortality for 
participants, 




















Table 12: Factors that place a patient at risk for mortality after NGT versus PEG 
placement  
 Type of 
enteral 
nutrition 
HR 95% CI of OR p value 
(Cox regression)  
Increased age 
(> 60 years) 
NGT 0.635 .285-1.417 .268 




or equal to 4) 
 
NGT 0.267 .049-1.444 .125 
PEG 1.296 .431-3.899 .645 
Interrupted 
NGT feeds 
NGT 2.102 .708-6.236 .181 
Low albumin 
(lower than or 
equal to 35 
g/L) 
 
NGT 0.958 .189-4.867 .959 
PEG 0.856 .286-2.560 .781 
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Note: HR: Hazard ratio; CI: Confidence intervals 
Although not independently contributing to mortality, increased age of patients who were 
recommended for a PEG was a factor which increased the risk of mortality by 1.5 times in 
these patients than in those who were younger than 60 years old. There was no greater risk 
for mortality in patients with an increased age who were recommended for an NGT.  
Patients with a high Charlson score who were recommended for a PEG had a 1.3 times 
greater risk of mortality than those who had a low Charlson score. There was no greater risk 
for mortality in patients with a high Charlson score who were recommend for an NGT.  Low 
albumin did not greatly increase the risk of mortality in patients with either an NGT or a 
PEG. Patients who had interrupted feeds whilst on NGT feeds had a 2.1 times higher risk of 
mortality than those who did not have interrupted feeds. No single hazard ratio was found to 
be significant, which means that although a variable can be linked to the possibility of a 
higher mortality rate, in this study there was no single variable that independently had an 
effect on survival time.  
Risk factors for morality post placement of PEG in participants with a single morbidity 
versus multiple morbidities  
Table 13 depicts the variables that were positively linked to a greater risk of mortality for 
participants with multiple morbidities who had a PEG versus those with a single morbidity 
who had a PEG.  
Table 13: Factors that place a patient with single and multiple morbidities at risk of 
mortality post PEG insertion  




(> 60 years) 
Multiple 
morbidity 
0.837 .555-1.262 .396 
Single 
morbidity 
1.462 .403- 5.313 .564 















Note: HR: Hazard ratio; CI: Confidence intervals. BMI data was only available for the patients who had a single 
morbidity  
A high Charlson score (>4), which indicates high level of comorbidities, and a low albumin 
level were risk factors for mortality post PEG placement in patients with multiple 
morbidities. A patient with a high Charlson score had a 2.9 times greater risk of mortality 
than a patient with a low Charlson score. A patient with multiple morbidities and a low 
albumin level had 1.3 times higher risk of mortality than those with an albumin count within 
normal levels.  
Increased age and a decreased BMI placed a patient with a single morbidity at greater risk for 
mortality post PEG placement. A patient aged over 60 years, with a single morbidity at the 
time of PEG placement, had a 1.5 times greater risk of death than one who was under the age 
of 60. A patient with a single morbidity and a low BMI who was fitted with a PEG, had a 1.4 
times greater risk of mortality than a participant whose BMI fell within the normal range.  
Again, no single hazard ratio was found to be significant, which means that although a 
variable can be linked to the possibility of a higher mortality rate, in this study there was no 
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1.366 .422- 4.422 .602 
Low albumin 
(lower than or 




















single variable that independently had an effect on survival time for participants with varying 
morbidities who had a PEG placed.  
 
Risk factors for mortality post placement of PEG in participants with both single and 
multiple morbidities  
Table 14 depicts the risk of mortality in participants with specific comorbidities, frequently 












Note: HR: Hazard ratio; CI: Confidence intervals 
 
For participants with morbidities who had a PEG placed, a risk factor analysis was done on 
specific comorbidities to determine which may pose the greatest risk of mortality post 
placement of enteral nutrition. Hypertension, diabetes and respiratory disease, which were the 
most common morbidities within the study sample, were included in the analysis. A 
participant with hypertension has a 2.3 times higher risk of mortality post PEG placement. A 
participant with hypertension and diabetes has a 2.3 times greater risk of mortality post 
placement. Respiratory disease posed a lesser risk of mortality post PEG placement, with a 
1.4 times greater chance of mortality if present than if not.  
  
Table 14: The risk of mortality in patients with specific comorbidities after PEG 
placement  
Comorbidity HR 95% CI of OR p value  
(Cox regression) 
Hypertension 2.3 .434-12.527 .323 
Hypertension 
and diabetes 
2.3 .251-21.360 .459 
Respiratory 
disease 
1.4 .398-4.816 .610 





No single comorbidity was noted to have independently affected survival rates in this study 















The rate of mortality in patients, in this study, who were recommended for and received, both 
short and long term enteral nutrition, was high both pre and post placement of tubes for the 
provision of enteral nutrition.  
 
The high mortality rate in participants who were awaiting enteral nutrition could be attributed 
to multiple factors. Participants who were recommended for NGT placement did not always 
have one placed. These participants would, contrary to the recommendation by a medical 
Doctor or an SLT, be receiving oral intake or, in the case of unconscious patients, be 
receiving only intravenous fluids. In the case of unconscious patients, enteral nutrition should 
be automatically placed (Lloyd & Powell-Tuck, 2004; Stroud et al., 2003), but as noted 
during a review of the study participants’ hospital folders, this was not always the case. A 





recommendation for NGT placement would be written in the hospital file, by the referring 
health professional, but the file would only note when the NGT was in situ, and not the 
reason for the delay in placement. 
 
It is concerning to note the high number of participants who did not have an NGT placed 
after it had been recommended by a health professional. A high percentage of patients in the 
study died whilst awaiting the placement of an NGT. The probable impact of a lack of 
nutrition via an NGT is similar to, and can be compared with, the reported impact of 
interrupted enteral nutrition which resulted in higher mortality (Beavan et al., 2010; Kim et 
al., 2012). This study noted a positive link between the risk of mortality (a 2.1 times greater 
risk) and interrupted NGT feeds. This result was not significant, so cannot be said to have had 
an independent effect on mortality in the study population, but can be noted as a risk factor 
linked to mortality.  
 
Survival time differed between participants who, following recommendation, had an NGT 
placed and those who did not. The median survival time was significantly longer (p=0.013) 
for patients who had an NGT placed (23 days) than patients who did not have an NGT placed 
(8 days). It is impossible to note whether the failure to place an NGT directly influenced 
mortality, as there are many confounding variables. When considering these variables, many 
of them could have affected survival time. The two groups were similar with regard to 
underlying medical condition, with participants presenting with an equal mix of medical 
conditions.  The majority of these including neurological followed by non-communicable 
diseases, communicable diseases, trauma and delirium. All participants had dysphagia, but 
the type of dysphagia present in participants who had an NGT placed versus those who did 
not could be important for survival. Oral phase dysphagia may affect a person’s ability to 
achieve adequate hydration and nutrition due to limited intake. Pharyngeal phase dysphagia 
could place a person at fatal risk if aspiration is a symptom of the disorder. In the sample of 
participants who had an NGT recommended, one third who did not have an NGT placed had 
a diagnosis of pharyngeal phase dysphagia. This could account for the poorer survival rate in 
patients who did not have an NGT placed following recommendation. These patients had a 
risk of aspiration which increased the likelihood of morbidity and mortality. The type of 
dysphagia could have been an influencing factor on mortality, as could the failure to initiate 
enteral nutrition intake after it is recommended.  






Also of concern is the high mean number of days (M: 2.74; range: 0-8) it took for an NGT to 
be placed post recommendation. Enteral nutrition is recommended in patients who are unable 
to maintain their hydration and nutritional requirements orally (Erdil et al., 2005; Holmes, 
2011). If enteral nutrition is not placed, after a recommendation is made, a patient will be at 
risk of inadequate or unsafe intake, which can have a detrimental effect on their outcome by 
increasing morbidity and mortality. This study noted no significant (p=.188) link between the 
timing of placement of an NGT and mortality. But important to note is that whilst the non-
immediate placement of an NGT had no effect on mortality, ultimate placement of an NGT 
post recommendation did have a significant effect on mortality, albeit only increasing median 
survival time by 15 days.  
  
In this study, the failure to place all the recommended NGTs highlights a lack of adherence to 
established guidelines on enteral nutrition recommendations and placement (Bankhead et al., 
2009; Kreymann et al., 2006; Loser et al., 2005; Westaby et al., 2010; Wilhelm et al., 2010). 
Guidelines for best practice are intended to ensure the best outcome for the patient, and 
should be adhered to. It would be beneficial to consider the reasons for the lack of placement 
in a future study so that better adherence to recommendations regarding enteral nutrition 
placement can be achieved, which would in turn benefit patients and could ensure more 
favourable outcomes in terms of survival rate.  
Mortality rates of participants who had an NGT placed were high. In this study, the majority 
of participants who had an NGT in situ died within 1 month of placement. The high mortality 
rates noted in participants who had an NGT in situ could be indicative of the underlying 
medical condition and/or the presence of dysphagia. The primary medical condition in 
participants with an NGT in situ was a neurological deficit. Mortality rates in patients who 
have suffered neurological fallout is high, particularly in the acute stages (Laskaratos et al., 
2013). The medical diagnosis of participants who had an NGT in situ could have therefore 
been a factor in the high mortality rates noted in this cohort. Participants who had an NGT in 
situ formed part of the cohort with multiple morbidities. The presence of multiple morbidities 
can place a patient at a greater risk of mortality, which too could explain the high mortality 
rates noted in this cohort. Many participants who had an NGT in situ experienced interrupted 
feeds, which was found to have a positive link to an increased risk of mortality, although it 
was not identified as an independent factor causing mortality.  
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The benefits of early enteral nutrition have been proven to affect outcomes of hospitalised 
patients. They have been linked specifically to shorter hospitalisation (Lloyd & Powell-Tuck, 
2004; Malmgren et al., 2011; Prosser-Loose & Paterson, 2006), improved nutrition, a lower 
rate of treatment failure (Kim et al., 2012) and lower morbidity and mortality (Hartl et al., 
2008). In this study over 80% of the participants who had an NGT placed died, although 
survival time was longer for patients who had an NGT versus those who did not. The positive 
outcomes that are mentioned within the literature, particularly that of lower mortality, were 
not noted in this study within the cohort of participants fitted with an NGT. The reasons for 
this could be attributed to underlying medical condition and the presence of a high level of 
comorbidity. 
Mortality rates were high in participants who were awaiting the placement of long term 
enteral nutrition. The rate was higher in participants who had multiple morbidities than those 
who had a single morbidity. In this study, a total of 37.3% (n=91) of patients died before 
PEG placement. In the cohort of participants with multiple morbidities, who died before 
placement had, as their underlying medical condition, a neurological deficit, had pharyngeal 
phase dysphagia and a high level of comorbidities as indicated by a high score on the 
Charlson Comorbidity Index. A patient’s underlying medical condition, as well as the 
presence of comorbidities, can place them at a higher risk of death (Blomberg et al., 2012; 
Erdil et al., 2005; Kirchgatterer et al., 2007). The presence of dysphagia, particularly 
pharyngeal phase dysphagia which can include aspiration, is also a risk factor for mortality 
(Carrion et al., 2014; Koidou, Kollias & Sdravou, 2014). This high level of morbidity and the 
presence of an underlying neurological condition in participants who were referred for PEG 
placement, contribute to the vulnerability of this cohort and could explain the high mortality 
rates. 
This cohort of participants were referred for PEG placement by an SLT. In this study it is not 
possible to comment on the period of time that a patient had been in hospital before a referral 
was made to an SLT for a dysphagia assessment. It is not possible then, to comment on the 
effect that a possible delay in referral to an SLT may have had on a participant’s outcome. If 
there was a delayed referral to an SLT, there may have been a delay in the recommendation 
for enteral nutrition, which could have affected outcomes.  Data was available in this study 





for comment to be made on the time lapse between the first dysphagia assessment by an SLT 
and the recommendation for a PEG.  
 
All patients who were recommend for a PEG by an SLT were receiving hydration and 
nutrition via an NGT at the time of PEG recommendation, but were considered PEG 
candidates due to the severity of dysphagia, or the lack of progress in therapy to remediate 
the swallow. If one considers the high mortality rate within one week of NGT placement, in 
this study, together with the fact that the majority of recommendations for PEG by an SLT 
took place within the first week after initial dysphagia assessment (Mean ± STD 4.78 ± 
3.373), one could conclude that the timing of PEG recommendations was too hasty. Patients 
who died either before NGT placement, or within one week of placement, are inappropriate 
candidates for PEG due to their high risk of mortality before PEG placement. In this study, 
participants who were referred too hastily for PEG placement, add to the mortality figures 
‘pre PEG placement’, when in fact they should never have been considered as candidates.  
 
Literature suggests the need to carefully assess a patient and identify all risk factors for 
mortality before a decision is made for the recommendation of a PEG. (O’Mahony, 2012; 
Playford, 2010; Richards et al., 2013; Tanswell et al., 2007). A patient who is considered a 
high risk for mortality should not be considered a candidate for the procedure as it would be a 
futile intervention. Better patient selection would improve the outcome of patients who are 
recommended for and fitted with a PEG (Kurien et al., 2010). The high mortality rate of 
participant’s pre PEG placement in this study highlights the lack of a holistic consideration of 
all factors that could influence outcome, before recommendation for is made PEG.   
 
Mortality figures post PEG placement in this study were higher than those noted in other 
studies. Mortality rate at 1 week post placement was 6.5%, which was higher than that 
reported in literature (Azzopardi & Ellul, 2013; Janes et al., 2005; Smith et al., 2008). At 30 
days post placement, the mortality rate was 22.6%, which was higher than that reported in 
some studies (Azzopardi & Ellul, 2013; Gumaste et al., 2014; Gundogan et al., 2014; 
Kirchgatterer et al., 2007; Lee et al., 2013; Paramsothy et al., 2009; Richter-Schrag et al., 
2011; Zopf et al., 2011) but equal to the rate in others (Malmgren et al., 2011; Smith et al., 
2008). The 90 and 180 day mortality rate in this study were 16.1% and 13% respectively. The 
90 day mortality rate was higher than some literature (Zopf et al., 2011) and lower than others 





(Janes et al., 2005; Malmgren et al., 2011). The 180 day mortality rate was also lower than 
that noted by Janes et al. (2005).  In participants for whom there was complete data for follow 
up until 6 months post PEG placement (n=21), only 1 participant was still alive at the end of 
the study period.  
It is noted that high mortality rates post PEG placement are not a result of the procedure 
(Erdil et al., 2005) and reasons for high mortality rates have been suggested. These include 1) 
poor timing in the placement of PEG (Abuksis et al., 2000), and 2) inappropriate patient 
selection (Blomberg et al., 2012; Erdil et al., 2005; Kirchgatterer et al., 2007; Kurien et al., 
2010; Laskaratos et al., 2013; Richards et al., 2013). 
The notion of poor timing in the placement of PEG is linked to poor patient selection. If a 
patient has an underlying medical condition that places them at risk for mortality, it can be 
argued that they would have died regardless, and early PEG insertion, at a time when they are 
at risk of death due to an underlying medical condition, means that they die with a PEG in 
situ which makes their death a statistic of mortality post PEG placement. To counteract early 
PEG placement, it is suggested that if a patient still requires a PEG after their condition has 
stabilised, and they are still alive to receive it, only then should it be considered. Abuksis et 
al. (2000) noted a lower mortality rate in patients who were deferred for PEG placement until 
they were discharged from hospital and if it was still required at 30 days post discharge. 
In this study there was no significant effect (p=0.221) on the timing between a PEG 
recommendation to PEG placement and mortality post placement. Participants who had a 
PEG placed one week versus one month after it was recommended did not survive 
significantly longer. Correspondingly, those who waited over a month after recommendation 
for PEG placement did not have a significantly longer survival than those who were fitted 
almost immediately. The large majority of patients in this study who had a PEG placed ended 
up dying, regardless of the timing of placement from recommendation.  
When analysing the results of this study, it would appear that the high mortality rates can be 
attributed to underlying participants underlying medical conditions, and level of morbidity. 
The mortality levels post PEG placement in this study could indicate poor patient selection, 
rather than the effect of timing on placement.    
A patients underlying medical condition, as well as the presence of morbidities can place 
them at risk for mortality, regardless of whether a PEG is placed or not. There are also a 





series of risk factors that have been identified as placing a patient at greater risk of mortality 
post PEG insertion. These include increased age, decreased body mass index, increased 
number of morbidities, and decreased blood albumin levels.  
These risk factors were analysed in this study, and were noted to have a positive link to the 
risk of mortality. None of the risk factors were found to be significant, which means that no 
single factor can be directly attributed to an increased mortality rate. These results caution a 
clinician to consider aspects such as increased age, decreased body mass index, increased 
number of morbidities and decreased blood albumin levels when making a recommendation 
for PEG placement.  
The primary medical condition in this study for participants who were recommended for long 
term enteral nutrition was non communicable diseases, more specifically head and neck 
cancer. This result is in contrast to, but still in line with, the majority of literature which cites 
neurological deficits to be the main indicator for the recommendation of a PEG and head and 
neck cancer as the second most common indicator (Barker et al., 2012; Blomberg et al., 2012; 
Erdil et al., 2005; Gumaste et al., 2014; Kirchgatterer et al., 2007; Kobayashi et al., 2002; 
Malmgren et al., 2011; Paramsothy et al., 2009; Richter-Schrag et al., 2011; Smoliner et al., 
2012). The second most common indicator for the placement of PEG was a neurological 
deficit. The population of patients who had a neurological deficit were at risk for death due to 
their underlying medical condition (Sabin, 2008). Patients with head and neck cancer have a 
5-year survival rate of 35-50%, but if in advanced stages at the time of treatment, this rate 
drops and can range from 0-50% (Semple, Sullivan, Dunwoody & Kernohan, 2004). Patients 
often wait too long before seeking medical attention, resulting in a late stage of cancer at the 
time of diagnosis (Sing & Subramaniam, 2006). The staging of cancer that a patient presented 
with was not collected within this study. It would be an interesting factor to consider when 
recommending intervention for nutrition in patients with head and neck cancer, as it would 
affect outcome and survival. If participants with head and neck cancer in this study were in 
the advanced stages of cancer, this may have reduced their survival time post PEG placement, 
and would have negatively affected the survival times of participants with a single morbidity 
who were fitted with PEG.  
The majority of participants who had a medical diagnosis of head and neck cancer, who were 
referred for PEG placement, fell into the cohort of participants who had a single morbidity. 
The majority of those with neurological fallout, who were referred for PEG placement, fell 





into the cohort of participants who had multiple morbidities. This study considered survival 
rates of patients with a single morbidity and those with multiple morbidities who had a PEG 
placed. Patients with a single morbidity survived for 54 days compared to patients with 
multiple morbidities who survived for 24 days. The survival times reflect the sentiment that a 
patient with multiple morbidities is at greater risk of early mortality post PEG insertion due to 
their fragile state (Kobayashi et al., 2002; Lang et al., 2004; Poulsen, 2009). Barker et al. 
(2012) considered the mortality rate in their study and concluded that, despite careful patient 
selection, the high mortality rate warns against PEG placement in patients with multiple 
morbidities.  
This study also compared the outcomes of participants fitted with PEG (with multiple 
morbidities and a single morbidity) to those who were identified as having multiple risk 
factors that would place them at risk for mortality post PEG insertion and as a result were not 
referred for PEG placement, but rather for oral palliative nutrition. Participants who received 
oral palliative nutrition survived for 19 days; only five days less than those who had multiple 
morbidities and underwent PEG placement and survived for 24 days. It could be argued that, 
the resources used to place a PEG in patients who will only survive an extra five days, should 
rather be reserved for those who will receive maximum benefit. Patients who did not receive 
a PEG, but who were on oral palliative nutrition, survived for only five days less that patients 
with multiple morbidities who had a PEG placed.  With survival time not much different 
between these two groups consideration should be given to the recommendation of an oral 
palliative approach rather than a PEG. This could spare valuable resources and avoid a futile 
procedure.  
If a patient is considered to be a high risk for mortality, certain procedures may be deemed 
futile, such as a procedure that will cause further suffering and no benefit (Holmes, 2011). 
The decision to place a PEG should be based on the perceived benefit it will bring to the 
patient (DeLegge et al., 2005) and if no benefit is presumed, then the procedure should not be 
done. A patient who is identified as a high risk for mortality post PEG placement should not 
receive a PEG but rather they and their families should be counselled on the risks that exist 
and the reasons for deferred placement. It can be argued that a survival time of an additional 
five days for patients with multiple morbidities who received PEG compared to those with 
multiple morbidities who were put onto oral palliative nutrition, is not sufficient to warrant 
the use of resources on a PEG which appears to be futile.  
 





A patient is often recommended for a PEG if they are showing no signs of recovering their 
swallow and have been on NGT feeds for an extended period of time. Conflicting evidence 
exists around the time frame of NGT intake and when a patient should be recommend for a 
PEG.  Most literature recommends NGT feeding in the acute stages of disease (Prosser-Loose 
& Paterson, 2006) for a time period of four to six weeks (Stroud et al., 2003). The majority of 
the patients in this study had, as per recommendations in literature, an NGT in situ for under 
six weeks.  At the point that NGT feeds had gone over the recommended time frame, a 
medical professional would have recommended a PEG for patients.  
The amount of time an NGT has been in situ is not the only consideration when deciding if a 
patient would benefit from a PEG. Literature notes that a PEG should be considered if a 
patient has been on NGT feeds for this period, is showing no signs of being able to feed 
orally and is at high risk for malnutrition (Stroud et al., 2003).  Given the high mortality rates 
post PEG insertion, it cannot stand that this is the only consideration in the decision to 
recommend a PEG or not. A major factor should be the determination of whether the 
patient’s prognosis justifies the intervention (Abuksis et al., 2004; Rio et al., 2010).   
The median survival time of participants with multiple morbidities, in this study, who 
demised with an NGT in situ, was 20 days. When one compares this to participants with 
multiple morbidities who were fitted with a PEG, the difference in survival time is only four 
days, with PEG participants surviving for 24 days. The result suggests that in patients with 
multiple morbidities, the placement of a PEG versus a patient remaining on NGT feeds, may 
lead to four additional days survival. This comparison in survival rates, again raises the 
question of whether participants with multiple morbidities should receive PEG placement, if 
median survival time in these participants versus those on NGT feeds was only four days 
longer.  
Ultimately, in this study the outcome for both, patients who were receiving intake via NGT 
and those receiving intake via a PEG was death, which is not favourable. This leaves no clear 
decision of which method of enteral nutrition is best to recommend within a cohort of 
participants with multiple morbidities. Important to consider though is that a patient with 
multiple morbidities who had a PEG inserted survived for a median of only four more days 
than a patient with multiple morbidities who had an NGT in situ at the time of death. These 
four days leads one to question whether a PEG procedure yielding these results is beneficial 
or futile. 
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When comparing participants with multiple morbidities to those with a single morbidity, and 
deciding which method of enteral nutrition is best, there are considerations to make. A patient 
with a single morbidity who had a PEG placed had the longest median survival time of 54 
days. A patient with multiple morbidities who had a PEG placed had a median survival time 
of 24 days and a 1.3 times greater risk of death if PEG was placed instead of NGT. Although 
a participant with a single morbidity with a PEG in situ survived for a longer median time 
than a participant with multiple morbidities with a PEG in situ, the ultimate outcome was 
mortality. There was not much difference in survival time of participants who received 
different forms on enteral nutrition (NGT versus PEG), with mortality as the outcome for a 
large majority of these participants.  
The results of this study highlight the need for other forms of intake to be considered before a 
PEG is recommended. A patient may wish to refuse a PEG procedure and remain on NGT or 
go home on an oral intake, even if it means that they will survive for fewer days than patients 
who may decide to have a PEG placed. This is a decision that needs to be honoured and 
respected by health care professionals (Daniel, Rhodes, Vitale & Shega, 2014).   
In participants with multiple morbidities, there was a minimal difference in the survival times 
of participants who were on oral palliative nutrition and those who received NGT feeds and 
PEG feeds. This leads one to conclude that in a cohort of patients with multiple morbidities it 
may be best to spare resources used in the placement of both NGT and PEG for the provision 
of nutrition and to consider discharging a patient on oral palliative nutrition, with education 
on maintaining hydration and nutrition orally in the safest way.   
Ultimately, based on the clear risk factors and definite poor outcome expected, a patient with 
multiple morbidities should not be considered for a PEG. This study noted a positive link 
between the risk of mortality in participants with multiple morbidities and PEG placement. A 
participant with a single morbidity was noted to have the highest median survival time in this 
study, but still needs to be considered on an individual basis with the risk factors weighted 
up. This study noted a positive link between the risk of mortality and a low body mass index 
and increased age in participants with a single morbidity. Although participants with a single 
morbidity survived for a longer period, risk factors for mortality post PEG placement still 
exist in this cohort. Although not noted in this study, good outcome in patients with head and 
neck cancer who undergo PEG placement and not only survive, but benefit from the 





nutritional value the PEG provides and move back onto a full oral diet when appropriate 
(Richter-Schrag et al., 2011; Wermker et al., 2012; Zuercher, Grosjean & Monnier, 2011).  
Based on the findings, of survival rates, in this study, a decision on the type of enteral 
nutrition to recommend in different cohorts of patients, cannot be definitively stated. The 
results aim to guide health professionals in decision making. In a cohort of patients who have 
multiple morbidities and have a poor prognosis, based on the factors that are identified as 
placing a patient at a higher risk for mortality after PEG (a high Charlson score, increased 
age, decreased BMI and decreased albumin levels), health care professionals need to strongly 
consider avoidance of any aggressive intervention with regards to enteral nutrition. In cases 
where a patient is considered a high risk for mortality should they have a PEG placed, a 
strong recommendation for a palliative approach, where enteral nutrition is avoided, should 
be discussed with the patient and their family. By considering the small difference in the 
survival times in this study of participants with multiple morbidities who had different forms 
of nutrition (oral palliative, NGT and PEG), health care professionals need to seriously 
consider whether a recommendation of enteral nutrition for these patients is appropriate. 
The decisions around the recommendation of enteral nutrition, particularly in very ill patients 
who have a poor prognosis, are not easy for health care professionals to make. Clear 
guidelines that are based on evidence based outcomes of patients who have had enteral 
nutrition placed are crucial in order to provide help to health care professionals to navigate 
the difficult decisions that are often clouded with human emotion. The results of this study 
reveal important findings on survival rates for different cohorts of participants and factors 
affecting survival. It is the hope of the researcher that these findings can be used as a starting 
point for health professionals when deciding on the recommendation for enteral nutrition in 
the adult population in the South African context. It is also the hope that there is careful 
assessment of the individual patient by a multi-disciplinary team, which must include 
counselling of the patient on possible outcomes of the procedure with a strong emphasis on 
patient autonomy as key in the decision making process.  
A role not often considered by Speech Therapists is that of palliative care. The results of this 
study highlight the need to consider this approach rather than an aggressive intervention in 
patients who cannot maintain hydration and nutrition orally, and who are at risk of mortality 
if fitted with a tube for the provision of enteral nutrition.  





The provision of artificial nutrition and hydration (ANH) to patients who are in the end stages 
of disease is debated within literature, and can evoke emotional responses (Dev, Dalal & 
Bruera, 2012). Many feel that to deprive a patient of hydration and nutrition is unethical and 
the situation can make health professionals uncomfortable (Bryon, de Casterle & Gastmans, 
2012; Delegge et al., 2005).  It is common for patients in the end stages of disease to have 
little or no oral intake (Stiles, 2013). In a study on nurses’ perceptions on ANH in palliative 
care, it was found that there were more clinical reasons given for the withholding of ANH 
than for giving it (Stiles, 2013). Reasons for why ANH should be given were emotive and not 
based on clinical fact (Stiles, 2013). Decisions to provide ANH which are based on emotion, 
and not clinical evidence, are not in the best interests of the patient, with each case being 
discussed individually (Dev et al., 2012).  
In practice, there comes a time, when a decision needs to be made about the hydration and 
nutrition of a patient in the end stages of disease. The Speech Therapist, involved in the 
assessment and treatment of dysphagia, is often the professional who, based on assessment 
findings that will best fit the patient’s current needs, is in a position to recommend a form of 
intake. It is crucial, therefore, that any medical professional who is managing a patient in the 
end stages of disease, including a Speech Therapist, have adequate training in the field of 
palliative care and ANH (Bryon et al., 2012; Stiles, 2013) or has the referral routes available 
to trained palliative care Doctors who can help with the decision around a patient’s hydration 
and nutrition needs. This may reduce the number of inappropriate referrals for tubes to 
provide both short and long term enteral nutrition.  A more conservative approach, based on 
the principles of palliative care, can be used.  
Referral sources for enteral nutrition were considered in this study. The results indicate that 
short term enteral nutrition via an NGT was recommended for dysphagia more often by an 
SLT than by a medical Doctor. This finding suggests that when assessing a patient both 
medical Doctors and SLTs are aware of the possibility of dysphagia and the need for enteral 
nutrition in patients with dysphagia as a method to help with delivery of hydration and 
nutrition. An SLT may be more aware than a medical Doctor of dysphagia and the need for 
enteral nutrition because it is within the SLTs scope of practice to assess and manage 
dysphagia specifically (Seidl et al., 2008). The fact that a greater number of patients were 
referred for enteral nutrition by an SLT may indicate that an SLT, conducting a full 
assessment as opposed to a screener that a medical doctor may conduct, is more aware of 
small degrees of difficulty caused by dysphagia. None of the participants in the study had an 





objective assessment, such as a videofluroscopy (VFSS), to diagnose pharyngeal phase 
dysphagia. The SLT conducted a bedside evaluation to assess the swallow and on the basis of 
the findings would infer the patient as having pharyngeal phase dysphagia. The reliability of 
the SLTs clinical assessment and interpretation of the signs of dysphagia noted could be 
challenged. A definitive diagnosis of pharyngeal phase dysphagia would require an objective 
assessment such as VFSS or fiberoptic endoscopic evaluation of the swallow (FEES). 
Of the participants in the study, all of whom had a diagnosis of dysphagia, only a third were 
recommended for short term enteral nutrition by a medical Doctor. It is concerning that the 
remaining two thirds of these participants, who had been treated by a medical Doctor at the 
time of referral to an SLT, were only referred for NGT placement when assessed by an SLT. 
A medical doctor will have first contact with a patient upon admission. If a patient is 
admitted over a weekend when an SLT may not be on duty, and not referred for NGT 
placement by a medical Doctor, the patient could be left at risk of dysphagia until an 
assessment by an SLT is done the following week.  
Literature notes that all patients who are admitted to hospital should be screened for 
dysphagia and malnutrition on admission, and placed on enteral nutrition immediately if 
needed (Bankhead et al., 2009; Scottish Intercollegiate Guidelines Network; Malmgren et al., 
2011). This study did not collect data on screening procedures post admission and cannot 
comment on whether dysphagia screening by medical Doctors occurs as a routine procedure 
when a patient is admitted with neurological damage. The discrepancy between the number 
of NGTs recommended by a medical Doctor and by an SLT could indicate the need for a 
dysphagia screening upon admission to ensure that all dysphagia patients are correctly 
identified in a timely manner in order to minimise risk in this population. Screening for 
dysphagia may not be the best use of a medical Doctors time due to the fact that they in short 
supply and have scarce skills that are best used for other procedures. A solution to this could 
be the introduction of a dysphagia screening protocol for other health care professionals, such 
as Nurses, to administer (Donovan et al., 2012; Freeland, Garrett, Pathak, Anderson & 
Daniels, 2012) 
This study also looked at the recommendation practices of long term enteral nutrition. Long 
term enteral nutrition was also recommended most often by an SLT but, in comparison to 
short term enteral nutrition, was placed more frequently after a recommendation was made by 
a medical Doctor rather than by an SLT. This may be because a Doctor who is referring for 





the placement of a PEG has a more direct line of contact with the gastrointestinal (GIT) 
Doctors who will perform the procedure and so are able to ensure better follow through for 
the procedure after it has been recommended. An SLT, however, who recommends a PEG 
needs to work through the medical Doctor in the ward who will contact GIT to consult on the 
patient. This finding may reveal the need for a greater focus on multi-disciplinary team 
(MDT) work where an SLT is able to consult directly with a GIT Doctor to discuss patient 
referrals for PEG placement.   
None of the participants with a single morbidity, who were recommended for PEG placement 
by a medical Doctor, were ever referred to an SLT for a dysphagia assessment. They were 
diagnosed with oral pharyngeal phase dysphagia by a medical Doctor and referred for a PEG. 
This finding, again, highlights the need for greater MDT work in the assessment and 
management of patients with dysphagia. The large majority of these participants had head 
and neck cancer. The awareness that a medical Doctor may have about the disease process in 
head and neck cancer may prompt a greater number of referrals for PEG placement than from 
another medical professional, and the belief that a dysphagia assessment by an SLT is not 
warranted as the patient will require enteral nutrition regardless. Some studies suggest that 
PEG placement in head and neck cancer patients can exacerbate dysphagia and reduce a 
patient’s ability to return to oral intake (Langmore, Krisciunas, Miloro, Evans & Cheng, 
2011) as patients become too reliant on PEG feeding. This alone would be a sufficient reason 
to refer these patients to an SLT for assessment to establish if oral feeding, alongside PEG 
feeds, is possible. Oral intake throughout a period of PEG feeding would help patients move 
back onto oral feeds in the future, if this was a possibility.  
Further evidence exists to support the involvement of an SLT in the assessment and treatment 
of patients with head and neck cancer. Langmore et al. (2011) highlight a need in head and 
neck cancer patients for the use of swallow manoeuvres via training from an SLT as opposed 
to compensatory strategies which can be suggested by a medical Doctor. It is important for an 
SLT to assess a patient with head and neck cancer and to determine the most optimal 
approach for each patient to be able to recover swallowing or to compensate for losses due to 
surgical or chemo-radiation intervention.  
Strong emphasis is placed upon a multi-disciplinary approach when assessing patients who 
may be recommended for long term enteral nutrition (O’Mahony, 2012; Playford, 2010; 
Tanswell et al., 2007). In this study the lack of referral of head and neck cancer patients and 





those with neurological fallout as a result of cardiac arrest, as well as the referral for PEG 
based solely on a Doctor’s recommendation, shows a lack of a multi-disciplinary approach. 
When plans for treatment were made, and before referral for a PEG, all patients should have 
been discussed at a team level, as well as with the patient and their family or caregiver.  
A more rigorous assessment procedure, by a multi-disciplinary team, for all patients who are 
considered for a recommendation for PEG needs to be put into place. This will ensure that all 
aspects that could affect outcome are considered and an informed decision based on the best 
interests of the patient can be made, which upholds the medical ethics of autonomy, 
beneficence and non-maleficence.  
  
Limitations to the Study 
While the main aims of the study were met, there were some unavoidable limitations that 
must be noted. The retrospective nature of the study resulted in many limitations. A major 
limitation of retrospective data collection is the possibility of missing data. This was 
experienced in the study, with regards to missing data for BMI in the cohort of participants 
with multiple morbidities. This resulted in the risk factor of low BMI being impossible to 
calculate in this cohort of participants.   
There were time constraints for the data collection period, due to the study being a Masters 
dissertation with a time limit for submission, from the point of registration. These constraints 
meant that only the number of patients who were referred for enteral nutrition in a specified 
time frame could be included in the study. This impacted on sample sizes for each of the 
cohorts and could have resulted in a lack of statistical significance of results. Many studies 
that analyse survival do so for a period of one year or more into. This study had to place a 
limit of six months on the follow up of participants, so as to meet the deadline of submission 
within the specified limit set by the University for postgraduate dissertation. A longer follow 
up period, along with a larger sample size, could have resulted in different results.   
There was a large number of participants who were lost to follow up, particularly in the 
cohort of participants with multiple morbidities who were fitted with a PEG. The 
retrospective nature of data collection for this cohort meant that follow up post the point of 
the last medical note in the patient file was not possible. It would have been impossible to 
collect prospective data on this cohort, because at the time that the study commenced, the 
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change in approach to the recommendations for PEG by an SLT working at CHBAH had 
already changed. The only way to collect data on participants who were referred for PEG 
placement under the old approach to the recommendation for PEG, was by using a 
retrospective approach.  
The loss to follow did impact on the sample size of participants whose survival times could 
be analysed. The effect of this can be noted in the high number of participants who fell under 
“censored” and not “event” in the statistical output tables found under the Kaplan Meier 
graphs. ‘Censoring’ means that the survival time could not be accurately determined, because 
there was missing data from some sets due to drop out or loss to follow up (Rich, Neely, 
Paniello, Voekler, Nussenbaum & Wang, 2010). Despite a high level of censoring on some of 
the Kaplan Meier graphs, significant differences in survival times were noted, which means 
that the results shown are useful and reliable.  
Implications for Future Research 
Future research in this area should focus on prospective data collection to limit the 
occurrence of missing data. It should also look to increase the sample sizes of each cohort, 
and include a longer follow up time of patients who are referred for enteral nutrition. 
Research should consider follow up of patients who are now managed under the new 
approach and placed on oral palliative nutrition instead of receiving a PEG. A structured 
follow up of these patients should be considered, with regards to checking on optimization of 
hydration and nutrition and safety under this management strategy. These participants could 
be followed up and reassessed for long term enteral nutrition, if appropriate, after which 
outcomes could be assessed on patients who have a PEG placed immediately versus those 
who return as an out-patient and have a PEG placed if prognosis is improved. Future research 
could look at including ‘improved nutritional status’ and ‘return to oral feeds’ as outcome 
measures, to be analysed, in different cohorts of adult patients fitted with long term enteral 
nutrition.  
Conclusion 
The aims of this study were met. There is a high mortality rate in patients who are 
recommended for, and fitted with, tubes for the provision of both short and long term enteral 





nutrition. The reasons for high mortality appear to be linked to the patient’s level of 
morbidity and their underlying medical condition. The high levels of mortality in the study 
population were not limited to a particular type of enteral nutrition but was high across 
cohorts regardless of the type of enteral nutrition placed. This leads one to conclude that a 
greater focus should be placed on a palliative approach to nutrition and hydration, with 
education on meeting hydration and nutritional needs in the safest way. This approach should 
be considered in patients who present with similar medical profiles to those in this study, as 
an aggressive approach that employs the use of enteral nutrition does not appear to reduce 
mortality or prolong survival greatly.  
This study highlights the need for any patient with dysphagia, with a single morbidity or 
multiple morbidities, who may require enteral nutrition, to be assessed and managed by a 
multi-disciplinary team in a holistic manner. An SLT should be involved in the assessment 
and management of all patients with dysphagia who may require enteral nutrition, and health 
care professionals need to be made more aware of the need for SLT dysphagia services to 
ensure appropriate referrals, in order to achieve optimal patient outcomes. All aspects linked 
to possible mortality must be considered, and risks and benefits weighted up, before a 
recommendation for enteral nutrition is made. In the decision making process for patients 
who are considered for the placement of enteral nutrition, the ethical considerations of 
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Appendix A: Charlson Comorbidity Index  
(Charlson, Pompei, Ales & MacKenzie, 1987) 
 
1. Indication  
Assess whether a patient will live long enough to benefit from a specific screening measure   
or medical intervention  
 
2. Scoring:  
Comorbidity Component (Apply 1 point to each unless otherwise noted)   
1. Myocardial Infarction   
2. Congestive Heart Failure   
3. Peripheral Vascular Disease   
4. Cerebrovascular Disease   
5. Dementia   





6. COPD   
7. Connective Tissue Disease   
8. Peptic Ulcer Disease   
9. Diabetes Mellitus (1 point uncomplicated, 2 points if end‐organ damage)   
10. Moderate to Severe Chronic Kidney Disease (2 points)   
11. Hemiplegia (2 points)   
12. Leukemia (2 points)   
13. Malignant Lymphoma (2 points)   
14. Solid Tumor (2 points, 6 points if metastatic)   
15. Liver Disease (1 point mild, 3 points if moderate to severe)   
16. AIDS (6 points)   
 
Age   
1. Age <40 years: 0 points  
2. Age 41‐50 years: 1 points   
3. Age 51‐60 years: 2 points   
4. Age 61‐70 years: 3 points   
5. Age 71‐80 years: 4 points  
Appendix B: Data collection tool  
 
Group # 
Patient code #### 
Sex # 




Primary medical condition ## 
Secondary medical condition ## 
RVD status # 




Patient state at assessment # 
Type of dysphagia # 
Risks and outcomes for enteral nutrition among adults with dysphagia at a tertiary level hospital in 
South Africa 
115 
Current method of intake # 
Method of intake recommended post assessment # 
Time frame of EN need # 
Enteral nutrition recommended # 
Enteral nutrition placed/in place # 
Albumin level #### 
Interrupted feeds documented # 
Demised before placement # 
Demised 1 day after placement # 
Demised within 7 days after placement # 
Demised within 30 days after placement # 
Demised within 6 months after placement # 
Demised within 1 year after placement # 
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Appendix D: Permission to amend the name of the study 





Approval to amend the name of the study was sought by the researcher. The D9 
documentation has been signed and approved by the Chair of The Departmental Research 
Committee, Shajila Singh (supervisor of the study) and by the HOD for Communication 
Sciences at The University of Cape Town. It has been sent to the post graduate office and is 
awaiting approval there. The name amendment with be updated on peoplesoft system as soon 
as it has been processed by the post graduate office. Please do not hesitate to contact the 
researcher should you require any further communication on this matter.  
Email: noodlekenny@gmail.com 
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Appendix E: Ethics approval letter from the internal ethics committee at Chris Hani 
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Baragwanath Academic Hospital 
Appendix F: Approval letter from the head of the Speech Therapy and Audiology 
Department to conduct research within the department
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Appendix G: Approval letter from the head of the GIT department to conduct research 
within the department  





Appendix H: Informed consent letter for participants to sign  
UNIVERSITY OF CAPE TOWN 
DIVISION OF COMMUNICATION SCIENCES AND DISORDERS 
 
PERMISSION TO TAKE PART IN A RESEARCH STUDY 
 
Risks and outcomes for enteral nutrition among adults with dysphagia at a tertiary level hospital 
in South Africa 
Who is conducting this study: This research study is being done by Nicoll Kenny, who works in 
Speech Therapy at CHBAH, as part of her Master’s degree study at the University of Cape Town.   
Purpose of the study: The purpose of the study is to see what happens to participants after they 
have had a tube put into their stomach to help to them to eat and drink.  
Why have you been selected to be a part of this study: You are being asked to take part in this 
study because you will have/ have had a tube placed into your stomach to help you with getting the 
necessary food and liquids for your well-being. 
What will be expected from you in this study: You will have to give the researcher permission to 
look at your hospital file and collect information like: your age; sex; weight and nutritional status; 
reasons why you are in the hospital; reasons why you needed the feeding tube; How you are eating 
now; Do you have any problems with swallowing.   
 
This information will be collected at 4 different times 5 different times: (i) at the beginning when 
they have the tube put in, (ii)  1 week later, (iii) 1 month later, (iv) 3 months later and (v) 6 months 
after the surgery. If you go home the researcher will phone you to ask you some questions about 
your feeding tube on the phone.  
This study is not harmful to you because the researcher will not be doing anything to you – but will 
review your hospital file and phone you after you leave hospital to ask you about your feeding tube 
and how it is working. You will not be paid for taking part in this study but the information that we 
get from all the patients may be helpful to other patients in the future who need feeding tubes.  
All the information that we get from your file will be kept private and will not be given to anybody 
else to look at. It will be locked away in a cabinet to keep it safe and your name will not be used so 
nobody will know that you took part in this study. At the end of the study all the information with 
your name will be destroyed.    
Research studies include people who have made a choice to take part. You can choose if you want to 
take part and you can change your mind at any point and say that you do not want to take part 
anymore. You will still get the best medical care and nobody will treat you differently if you do not 
want to take part. 
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If you have any questions about the study and concerns: You may contact the researcher Nicoll 
Kenny at noodlekenny@gmail.com or 082 902 1054; or her supervisor, Prof Shajila Singh at 
Shajila.singh@uct.ac.za 
For serious concern about your rights or welfare within the study please contact: The Chair of the 
University of Cape Town’s Faculty of Health Sciences, Human Research Ethics Committee – Prof 
Marc Blockman at marc.blockman@uct.ac.za 
If you wish to participate in this study, you should sign below. 
Noted: I have been given a chance to ask any questions that I have about the research I am agreeing 
to take part in. 
Date Participant's Signature for Consent 
Date Person Obtaining Consent 





Appendix I: Consent letter for participant’s family member or guardian to sign in the event 
that the participant cannot sign consent to participate in the study  
  UNIVERSITY OF CAPE TOWN 
DIVISION OF COMMUNICATION SCIENCES AND DISORDERS 
 
PERMISSION TO TAKE PART IN A RESEARCH STUDY 
 
Risks and outcomes for enteral nutrition among adults with dysphagia at a tertiary level hospital 
in South Africa 
Who is conducting this study: This research study is being done by Nicoll Kenny, who works in 
Speech Therapy at CHBAH, as part of her Master’s degree study at the University of Cape Town.   
Purpose of the study: The purpose of the study is to see what happens to participants after they 
have had a tube put into their stomach to help to them to eat and drink.  
Why has your family member been selected to be a part of this study: They are being asked to take 
part in this study because they will have/ have had a tube placed into their stomach to help them 
with getting the necessary food and liquids for their well-being. 
What will be expected from them in this study: You will have to give the researcher permission to 
look at their hospital file and collect information like: their age; sex; weight and nutritional status; 
reasons why they are in the hospital; reasons why they needed the feeding tube; how they are 
eating now; if they have any problems with swallowing. 
   
This information will be collected at 5 different times: (i) at the beginning when they have the tube 
put in, (ii)  1 week later, (iii) 1 month later, (iv) 3 months later and (v) 6 months after the surgery. If 
they go home the researcher will phone you to answer some questions about their feeding tube on 
the phone.  
This study is not harmful to them because the researcher will not be doing anything to them – but 
will review their hospital file and phone you after you leave hospital to ask you about their feeding 
tube and how it is working. They will not be paid for taking part in this study but the information that 
we get from all the patients may be helpful to other patients in the future who need feeding tubes.  
All the information that we get from their file will be kept private and will not be given to anybody 
else to look at. It will be locked away in a cabinet to keep it safe and their name will not be used so 
nobody will know that they took part in this study. At the end of the study all the information with 
their name will be destroyed.    
Research studies include people who have made a choice to take part. You can choose if you want 
your family member to take part and you can change your mind at any point and say that you do not 
want them to take part anymore. They will still get the best medical care and nobody will treat them 
differently if you do not want them to take part. 





Should your family member be able to give their consent in the future when they are recovered, 
they will be approached by the researcher to sign consent for themselves to continue taking part in 
the study.  
If you have any questions about the study and concerns: You may contact the researcher Nicoll 
Kenny at noodlekenny@gmail.com or 082 902 1054; or her supervisor, Prof Shajila Singh at 
Shajila.singh@uct.ac.za 
For serious concerns about your family members rights or welfare within the study please contact: 
The Chair of the University of Cape Town’s Faculty of Health Sciences, Human Research Ethics 
Committee – Prof Marc Blockman at marc.blockman@uct.ac.za 
If you wish to participate in this study, you should sign below. 
Noted: I have been given a chance to ask any questions that I have about the research I am agreeing 
to allow my family member to take part in. 
 
 
            
Date                       Guardian / family member’s signature for consent on behalf of patient 
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